{"title_page": "Pogost, Seletsky Selsoviet, Kholmogorsky District, Arkhangelsk Oblast", "text_new": "{{Infobox settlement\n|official_name          = Pogost\n|other_name             = \n|native_name            = \u041f\u043e\u0433\u043e\u0441\u0442\n|nickname               = \n|settlement_type        = Village\n|image_skyline          = \n|image_caption          = \n|pushpin_map            = Russia Arkhangelsk Oblast#Russia\n|pushpin_label_position = \n|pushpin_mapsize        =\n|pushpin_map_caption    = \n|subdivision_type       = Country\n|subdivision_name       = [[Russia]]\n|subdivision_type1      = [[List of regions of Russia|Region]] \n|subdivision_name1      = [[Arkhangelsk Oblast]]\n|subdivision_type2      = [[Counties of Russia|County]] \n|subdivision_name2      = \n|subdivision_type3      = [[Districts of Russia|District]] \n|subdivision_name3      = [[Kholmogorsky District]]\n|subdivision_type4      = [[List of municipalities of Russia|Municipality]]\n|subdivision_name4      = \n|timezone1              =\n|utc_offset1            = +3:00\n|timezone1_DST          = \n|utc_offset1_DST        = \n|postal_code_type       = \n|postal_code            = \n|elevation_m            = \n|elevation_footnotes    = \n|coordinates            = {{coord|63|19|N|41|23|E|display=inline}}\n}}\n'''Pogost''' ({{lang-ru|\u041f\u043e\u0433\u043e\u0441\u0442}}) is a [[types of inhabited localities in Russia|rural locality]] (a [[Village#Russia|village]]) in Seletskoye Rural Settlement of [[Kholmogorsky District]], [[Arkhangelsk Oblast]], Russia. The population was 464 as of 2010.<ref name=\"arhangelskstat\">{{cite web|url=http://arhangelskstat.gks.ru/wps/wcm/connect/rosstat_ts/arhangelskstat/resources/2edc58004f857ef7ae20af9b972d8349/%D1%87%D0%B8%D1%81%D0%BB%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C.doc|website=arhangelskstat.gks.ru|title=\u0412\u0441\u0435\u0440\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u043f\u0435\u0440\u0435\u043f\u0438\u0441\u044c \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u0438\u044f 2010 \u0433\u043e\u0434\u0430. \u0427\u0438\u0441\u043b\u0435\u043d\u043d\u043e\u0441\u0442\u044c \u043f\u043e \u043c\u0443\u043d\u0438\u0446\u0438\u043f\u0430\u043b\u044c\u043d\u044b\u043c \u043e\u0431\u0440\u0430\u0437\u043e\u0432\u0430\u043d\u0438\u044f\u043c \u0438 \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u043d\u044b\u043c \u043f\u0443\u043d\u043a\u0442\u0430\u043c \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438|accessdate=2019-02-19}}</ref>\n\n== References ==\n{{reflist}}\n\n{{Rural localities in Kholmogorsky District}}\n{{Authority control}}\n\n[[Category:Rural localities in Arkhangelsk Oblast]]\n[[Category:Rural localities in Kholmogorsky District]]\n[[Category:Kholmogorsky Uyezd]]\n{{ArkhangelskOblast-geo-stub}}\n", "text_old": "{{Infobox settlement\n|official_name          = Pogost\n|other_name             = \n|native_name            = \u041f\u043e\u0433\u043e\u0441\u0442\n|nickname               = \n|settlement_type        = Village\n|image_skyline          = \n|image_caption          = \n|pushpin_map            = Russia Arkhangelsk Oblast#Russia\n|pushpin_label_position = \n|pushpin_mapsize        =\n|pushpin_map_caption    = \n|subdivision_type       = Country\n|subdivision_name       = [[Russia]]\n|subdivision_type1      = [[List of regions of Russia|Region]] \n|subdivision_name1      = [[Arkhangelsk Oblast]]\n|subdivision_type2      = [[Counties of Russia|County]] \n|subdivision_name2      = \n|subdivision_type3      = [[Districts of Russia|District]] \n|subdivision_name3      = [[Kholmogorsky District]]\n|subdivision_type4      = [[List of municipalities of Russia|Municipality]]\n|subdivision_name4      = \n|timezone1              =\n|utc_offset1            = +3:00\n|timezone1_DST          = \n|utc_offset1_DST        = \n|postal_code_type       = \n|postal_code            = \n|elevation_m            = \n|elevation_footnotes    = \n|coordinates            = {{coord|63|19|N|41|23|E|display=inline}}\n}}\n'''Pogost''' ({{lang-ru|\u041f\u043e\u0433\u043e\u0441\u0442}}) is a [[types of inhabited localities in Russia|rural locality]] (a [[Village#Russia|village]]) in Seletskoye Rural Settlement of [[Kholmogorsky District]], [[Arkhangelsk Oblast]], Russia. The population was 464 as of 2010.<ref name=\"arhangelskstat\">{{cite web|url=http://arhangelskstat.gks.ru/wps/wcm/connect/rosstat_ts/arhangelskstat/resources/2edc58004f857ef7ae20af9b972d8349/%D1%87%D0%B8%D1%81%D0%BB%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C.doc|website=arhangelskstat.gks.ru|title=\u0412\u0441\u0435\u0440\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u043f\u0435\u0440\u0435\u043f\u0438\u0441\u044c \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u0438\u044f 2010 \u0433\u043e\u0434\u0430. \u0427\u0438\u0441\u043b\u0435\u043d\u043d\u043e\u0441\u0442\u044c \u043f\u043e \u043c\u0443\u043d\u0438\u0446\u0438\u043f\u0430\u043b\u044c\u043d\u044b\u043c \u043e\u0431\u0440\u0430\u0437\u043e\u0432\u0430\u043d\u0438\u044f\u043c \u0438 \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u043d\u044b\u043c \u043f\u0443\u043d\u043a\u0442\u0430\u043c \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438|accessdate=2019-02-19}}</ref>\n\n== References ==\n{{reflist}}\n\n{{Rural localities in Kholmogorsky District}}\n{{Authority control}}\n\n[[Category:Rural localities in Arkhangelsk Oblast]]\n[[Category:Rural localities in Kholmogorsky District]]\n[[Category:Kholmogorsky Uyezd]]\n\n{{ArkhangelskOblast-geo-stub}}\n", "name_user": "Wagino 20100516", "label": "safe", "comment": "\u2192\u200eReferences:clean up", "url_page": "//en.wikipedia.org/wiki/Pogost,_Seletsky_Selsoviet,_Kholmogorsky_District,_Arkhangelsk_Oblast"}
{"title_page": "Pochtovoye", "text_new": "{{Infobox settlement\n|official_name          = Pochtovoye\n|other_name             = \n|native_name            = \u041f\u043e\u0447\u0442\u043e\u0432\u043e\u0435\n|nickname               = \n|settlement_type        = Settlement\n|image_skyline          = \n|image_caption          = \n|pushpin_map            = Russia Arkhangelsk Oblast#Russia\n|pushpin_label_position = \n|pushpin_mapsize        =\n|pushpin_map_caption    = \n|subdivision_type       = Country\n|subdivision_name       = [[Russia]]\n|subdivision_type1      = [[List of regions of Russia|Region]] \n|subdivision_name1      = [[Arkhangelsk Oblast]]\n|subdivision_type2      = [[Counties of Russia|County]] \n|subdivision_name2      = \n|subdivision_type3      = [[Districts of Russia|District]] \n|subdivision_name3      = [[Kholmogorsky District]]\n|subdivision_type4      = [[List of municipalities of Russia|Municipality]]\n|subdivision_name4      = \n|timezone1              = \n|utc_offset1            = +3:00\n|timezone1_DST          = \n|utc_offset1_DST        = \n|postal_code_type       = \n|postal_code            = \n|elevation_m            = \n|elevation_footnotes    = \n|coordinates            = {{coord|63|09|N|42|01|E|display=inline}}<ref>[https://mapdata.ru/arhangelskaya-oblast/holmogorskiy-rayon/poselok-pochtovoe/ \u041a\u0430\u0440\u0442\u0430 \u043f\u043e\u0441\u0435\u043b\u043a\u0430 \u041f\u043e\u0447\u0442\u043e\u0432\u043e\u0435 \u0432 \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438]</ref>\n}}\n'''Pochtovoye''' ({{lang-ru|\u041f\u043e\u0447\u0442\u043e\u0432\u043e\u0435}}) is a [[types of inhabited localities in Russia|rural locality]] (a [[Village#Russia|settlement]]) in Yemetskoye Rural Settlement of [[Kholmogorsky District]], [[Arkhangelsk Oblast]], Russia. The population was 205 as of 2010.<ref name=\"arhangelskstat\">{{cite web|url=http://arhangelskstat.gks.ru/wps/wcm/connect/rosstat_ts/arhangelskstat/resources/2edc58004f857ef7ae20af9b972d8349/%D1%87%D0%B8%D1%81%D0%BB%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C.doc|website=arhangelskstat.gks.ru|title=\u0412\u0441\u0435\u0440\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u043f\u0435\u0440\u0435\u043f\u0438\u0441\u044c \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u0438\u044f 2010 \u0433\u043e\u0434\u0430. \u0427\u0438\u0441\u043b\u0435\u043d\u043d\u043e\u0441\u0442\u044c \u043f\u043e \u043c\u0443\u043d\u0438\u0446\u0438\u043f\u0430\u043b\u044c\u043d\u044b\u043c \u043e\u0431\u0440\u0430\u0437\u043e\u0432\u0430\u043d\u0438\u044f\u043c \u0438 \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u043d\u044b\u043c \u043f\u0443\u043d\u043a\u0442\u0430\u043c \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438|accessdate=2019-02-19}}</ref>\n\n== References ==\n{{reflist}}\n\n{{Rural localities in Kholmogorsky District}}\n{{Authority control}}\n\n[[Category:Rural localities in Arkhangelsk Oblast]]\n[[Category:Rural localities in Kholmogorsky District]]\n\n{{ArkhangelskOblast-geo-stub}}\n", "text_old": "{{Infobox settlement\n|official_name          = Pochtovoye\n|other_name             = \n|native_name            = \u041f\u043e\u0447\u0442\u043e\u0432\u043e\u0435\n|nickname               = \n|settlement_type        = Settlement\n|image_skyline          = \n|image_caption          = \n|pushpin_map            = Russia Arkhangelsk Oblast#Russia\n|pushpin_label_position = \n|pushpin_mapsize        =\n|pushpin_map_caption    = \n|subdivision_type       = Country\n|subdivision_name       = [[Russia]]\n|subdivision_type1      = [[List of regions of Russia|Region]] \n|subdivision_name1      = [[Arkhangelsk Oblast]]\n|subdivision_type2      = [[Counties of Russia|County]] \n|subdivision_name2      = \n|subdivision_type3      = [[Districts of Russia|District]] \n|subdivision_name3      = [[Kholmogorsky District]]\n|subdivision_type4      = [[List of municipalities of Russia|Municipality]]\n|subdivision_name4      = \n|timezone1              = \n|utc_offset1            = +3:00\n|timezone1_DST          = \n|utc_offset1_DST        = \n|postal_code_type       = \n|postal_code            = \n|elevation_m            = \n|elevation_footnotes    = \n|coordinates            = {{coord|63|09|N|42|01|E|display=inline}}<ref>[https://mapdata.ru/arhangelskaya-oblast/holmogorskiy-rayon/poselok-pochtovoe/ \u041a\u0430\u0440\u0442\u0430 \u043f\u043e\u0441\u0435\u043b\u043a\u0430 \u041f\u043e\u0447\u0442\u043e\u0432\u043e\u0435 \u0432 \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438]</ref>\n}}\n'''Pochtovoye''' ({{lang-ru|\u041f\u043e\u0447\u0442\u043e\u0432\u043e\u0435}}) is a [[types of inhabited localities in Russia|rural locality]] (a [[Village#Russia|settlement]]) in Yemetskoye Rural Settlement of [[Kholmogorsky District]], [[Arkhangelsk Oblast]], Russia. The population was 205 as of 2010.<ref name=\"arhangelskstat\">{{cite web|url=http://arhangelskstat.gks.ru/wps/wcm/connect/rosstat_ts/arhangelskstat/resources/2edc58004f857ef7ae20af9b972d8349/%D1%87%D0%B8%D1%81%D0%BB%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C.doc|website=arhangelskstat.gks.ru|title=\u0412\u0441\u0435\u0440\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u043f\u0435\u0440\u0435\u043f\u0438\u0441\u044c \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u0438\u044f 2010 \u0433\u043e\u0434\u0430. \u0427\u0438\u0441\u043b\u0435\u043d\u043d\u043e\u0441\u0442\u044c \u043f\u043e \u043c\u0443\u043d\u0438\u0446\u0438\u043f\u0430\u043b\u044c\u043d\u044b\u043c \u043e\u0431\u0440\u0430\u0437\u043e\u0432\u0430\u043d\u0438\u044f\u043c \u0438 \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u043d\u044b\u043c \u043f\u0443\u043d\u043a\u0442\u0430\u043c \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438|accessdate=2019-02-19}}</ref>\n\n== References ==\n{{reflist}}\n\n{{Rural localities in Kholmogorsky District}}\n{{Authority control}}\n\n[[Category:Rural localities in Arkhangelsk Oblast]]\n[[Category:Rural localities in Kholmogorsky District]]\n\n\n{{ArkhangelskOblast-geo-stub}}\n", "name_user": "Wagino 20100516", "label": "safe", "comment": "\u2192\u200eReferences:clean up", "url_page": "//en.wikipedia.org/wiki/Pochtovoye"}
{"title_page": "Plakhino, Kholmogorsky District, Arkhangelsk Oblast", "text_new": "{{Other places|Plakhino}}\n{{Infobox settlement\n|official_name          = Plakhino\n|other_name             = \n|native_name            = \u041f\u043b\u0430\u0445\u0438\u043d\u043e\n|nickname               = \n|settlement_type        = Village\n|image_skyline          = \n|image_caption          = \n|pushpin_map            = Russia Arkhangelsk Oblast#Russia\n|pushpin_label_position = \n|pushpin_mapsize        =\n|pushpin_map_caption    = \n|subdivision_type       = Country\n|subdivision_name       = [[Russia]]\n|subdivision_type1      = [[List of regions of Russia|Region]] \n|subdivision_name1      = [[Arkhangelsk Oblast]]\n|subdivision_type2      = [[Counties of Russia|County]] \n|subdivision_name2      = \n|subdivision_type3      = [[Districts of Russia|District]] \n|subdivision_name3      = [[Kholmogorsky District]]\n|subdivision_type4      = [[List of municipalities of Russia|Municipality]]\n|subdivision_name4      = \n|timezone1              =\n|utc_offset1            = +3:00\n|timezone1_DST          = \n|utc_offset1_DST        = \n|postal_code_type       = \n|postal_code            = \n|elevation_m            = \n|elevation_footnotes    = \n|coordinates            = {{coord|63|31|N|41|56|E|display=inline}}<ref>[https://mapdata.ru/arhangelskaya-oblast/holmogorskiy-rayon/derevnya-plahino/ \u041a\u0430\u0440\u0442\u0430 \u0434\u0435\u0440\u0435\u0432\u043d\u0438 \u041f\u043b\u0430\u0445\u0438\u043d\u043e \u0432 \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438]</ref>\n}}\n'''Plakhino''' ({{lang-ru|\u041f\u043b\u0430\u0445\u0438\u043d\u043e}}) is a [[types of inhabited localities in Russia|rural locality]] (a [[Village#Russia|village]]) in Khavrogorskoye Rural Settlement of [[Kholmogorsky District]], [[Arkhangelsk Oblast]], Russia. The population was 9 as of 2010.<ref name=\"arhangelskstat\">{{cite web|url=http://arhangelskstat.gks.ru/wps/wcm/connect/rosstat_ts/arhangelskstat/resources/2edc58004f857ef7ae20af9b972d8349/%D1%87%D0%B8%D1%81%D0%BB%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C.doc|website=arhangelskstat.gks.ru|title=\u0412\u0441\u0435\u0440\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u043f\u0435\u0440\u0435\u043f\u0438\u0441\u044c \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u0438\u044f 2010 \u0433\u043e\u0434\u0430. \u0427\u0438\u0441\u043b\u0435\u043d\u043d\u043e\u0441\u0442\u044c \u043f\u043e \u043c\u0443\u043d\u0438\u0446\u0438\u043f\u0430\u043b\u044c\u043d\u044b\u043c \u043e\u0431\u0440\u0430\u0437\u043e\u0432\u0430\u043d\u0438\u044f\u043c \u0438 \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u043d\u044b\u043c \u043f\u0443\u043d\u043a\u0442\u0430\u043c \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438|accessdate=2019-02-19}}</ref>\n\n== References ==\n{{reflist}}\n\n{{Rural localities in Kholmogorsky District}}\n{{Authority control}}\n\n[[Category:Rural localities in Arkhangelsk Oblast]]\n[[Category:Rural localities in Kholmogorsky District]]\n\n{{ArkhangelskOblast-geo-stub}}\n", "text_old": "{{Other places|Plakhino}}\n{{Infobox settlement\n|official_name          = Plakhino\n|other_name             = \n|native_name            = \u041f\u043b\u0430\u0445\u0438\u043d\u043e\n|nickname               = \n|settlement_type        = Village\n|image_skyline          = \n|image_caption          = \n|pushpin_map            = Russia Arkhangelsk Oblast#Russia\n|pushpin_label_position = \n|pushpin_mapsize        =\n|pushpin_map_caption    = \n|subdivision_type       = Country\n|subdivision_name       = [[Russia]]\n|subdivision_type1      = [[List of regions of Russia|Region]] \n|subdivision_name1      = [[Arkhangelsk Oblast]]\n|subdivision_type2      = [[Counties of Russia|County]] \n|subdivision_name2      = \n|subdivision_type3      = [[Districts of Russia|District]] \n|subdivision_name3      = [[Kholmogorsky District]]\n|subdivision_type4      = [[List of municipalities of Russia|Municipality]]\n|subdivision_name4      = \n|timezone1              =\n|utc_offset1            = +3:00\n|timezone1_DST          = \n|utc_offset1_DST        = \n|postal_code_type       = \n|postal_code            = \n|elevation_m            = \n|elevation_footnotes    = \n|coordinates            = {{coord|63|31|N|41|56|E|display=inline}}<ref>[https://mapdata.ru/arhangelskaya-oblast/holmogorskiy-rayon/derevnya-plahino/ \u041a\u0430\u0440\u0442\u0430 \u0434\u0435\u0440\u0435\u0432\u043d\u0438 \u041f\u043b\u0430\u0445\u0438\u043d\u043e \u0432 \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438]</ref>\n}}\n'''Plakhino''' ({{lang-ru|\u041f\u043b\u0430\u0445\u0438\u043d\u043e}}) is a [[types of inhabited localities in Russia|rural locality]] (a [[Village#Russia|village]]) in Khavrogorskoye Rural Settlement of [[Kholmogorsky District]], [[Arkhangelsk Oblast]], Russia. The population was 9 as of 2010.<ref name=\"arhangelskstat\">{{cite web|url=http://arhangelskstat.gks.ru/wps/wcm/connect/rosstat_ts/arhangelskstat/resources/2edc58004f857ef7ae20af9b972d8349/%D1%87%D0%B8%D1%81%D0%BB%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C.doc|website=arhangelskstat.gks.ru|title=\u0412\u0441\u0435\u0440\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u043f\u0435\u0440\u0435\u043f\u0438\u0441\u044c \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u0438\u044f 2010 \u0433\u043e\u0434\u0430. \u0427\u0438\u0441\u043b\u0435\u043d\u043d\u043e\u0441\u0442\u044c \u043f\u043e \u043c\u0443\u043d\u0438\u0446\u0438\u043f\u0430\u043b\u044c\u043d\u044b\u043c \u043e\u0431\u0440\u0430\u0437\u043e\u0432\u0430\u043d\u0438\u044f\u043c \u0438 \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u043d\u044b\u043c \u043f\u0443\u043d\u043a\u0442\u0430\u043c \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438|accessdate=2019-02-19}}</ref>\n\n== References ==\n{{reflist}}\n\n{{Rural localities in Kholmogorsky District}}\n{{Authority control}}\n\n[[Category:Rural localities in Arkhangelsk Oblast]]\n[[Category:Rural localities in Kholmogorsky District]]\n\n\n{{ArkhangelskOblast-geo-stub}}\n", "name_user": "Wagino 20100516", "label": "safe", "comment": "\u2192\u200eReferences:clean up", "url_page": "//en.wikipedia.org/wiki/Plakhino,_Kholmogorsky_District,_Arkhangelsk_Oblast"}
{"title_page": "Malaya Tovra", "text_new": "{{Infobox settlement\n|official_name          = Malaya Tovra\n|other_name             = \n|native_name            = \u041c\u0430\u043b\u0430\u044f \u0422\u043e\u0432\u0440\u0430\n|nickname               = \n|settlement_type        = Settlement\n|image_skyline          = \n|image_caption          = \n|pushpin_map            = Russia Arkhangelsk Oblast#Russia\n|pushpin_label_position = \n|pushpin_mapsize        =\n|pushpin_map_caption    = \n|subdivision_type       = Country\n|subdivision_name       = [[Russia]]\n|subdivision_type1      = [[List of regions of Russia|Region]] \n|subdivision_name1      = [[Arkhangelsk Oblast]]\n|subdivision_type2      = [[Counties of Russia|County]] \n|subdivision_name2      = \n|subdivision_type3      = [[Districts of Russia|District]] \n|subdivision_name3      = [[Kholmogorsky District]]\n|subdivision_type4      = [[List of municipalities of Russia|Municipality]]\n|subdivision_name4      = \n|timezone1              = \n|utc_offset1            = +3:00\n|timezone1_DST          = \n|utc_offset1_DST        = \n|postal_code_type       = \n|postal_code            = \n|elevation_m            = \n|elevation_footnotes    = \n|coordinates            = {{coord|64|06|N|41|42|E|display=inline}}<ref>[https://mapdata.ru/arhangelskaya-oblast/holmogorskiy-rayon/poselok-malaya-tovra/ \u041a\u0430\u0440\u0442\u0430 \u043f\u043e\u0441\u0435\u043b\u043a\u0430 \u041c\u0430\u043b\u0430\u044f \u0422\u043e\u0432\u0440\u0430 \u0432 \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438]</ref>\n}}\n'''Malaya Tovra''' ({{lang-ru|\u041c\u0430\u043b\u0430\u044f \u0422\u043e\u0432\u0440\u0430}}) is a [[types of inhabited localities in Russia|rural locality]] (a [[Village#Russia|settlement]]) in Matigorskoye Rural Settlement of [[Kholmogorsky District]], [[Arkhangelsk Oblast]], Russia. The population was 138 as of 2010.<ref name=\"arhangelskstat\">{{cite web|url=http://arhangelskstat.gks.ru/wps/wcm/connect/rosstat_ts/arhangelskstat/resources/2edc58004f857ef7ae20af9b972d8349/%D1%87%D0%B8%D1%81%D0%BB%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C.doc|website=arhangelskstat.gks.ru|title=\u0412\u0441\u0435\u0440\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u043f\u0435\u0440\u0435\u043f\u0438\u0441\u044c \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u0438\u044f 2010 \u0433\u043e\u0434\u0430. \u0427\u0438\u0441\u043b\u0435\u043d\u043d\u043e\u0441\u0442\u044c \u043f\u043e \u043c\u0443\u043d\u0438\u0446\u0438\u043f\u0430\u043b\u044c\u043d\u044b\u043c \u043e\u0431\u0440\u0430\u0437\u043e\u0432\u0430\u043d\u0438\u044f\u043c \u0438 \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u043d\u044b\u043c \u043f\u0443\u043d\u043a\u0442\u0430\u043c \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438|accessdate=2019-02-19|archive-url=https://web.archive.org/web/20130927112811/http://arhangelskstat.gks.ru/wps/wcm/connect/rosstat_ts/arhangelskstat/resources/2edc58004f857ef7ae20af9b972d8349/%D1%87%D0%B8%D1%81%D0%BB%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C.doc|archive-date=2013-09-27|url-status=dead}}</ref>\n\n== References ==\n{{reflist}}\n\n{{Rural localities in Kholmogorsky District}}\n{{Authority control}}\n\n[[Category:Rural localities in Arkhangelsk Oblast]]\n[[Category:Rural localities in Kholmogorsky District]]\n\n{{ArkhangelskOblast-geo-stub}}\n", "text_old": "{{Infobox settlement\n|official_name          = Malaya Tovra\n|other_name             = \n|native_name            = \u041c\u0430\u043b\u0430\u044f \u0422\u043e\u0432\u0440\u0430\n|nickname               = \n|settlement_type        = Settlement\n|image_skyline          = \n|image_caption          = \n|pushpin_map            = Russia Arkhangelsk Oblast#Russia\n|pushpin_label_position = \n|pushpin_mapsize        =\n|pushpin_map_caption    = \n|subdivision_type       = Country\n|subdivision_name       = [[Russia]]\n|subdivision_type1      = [[List of regions of Russia|Region]] \n|subdivision_name1      = [[Arkhangelsk Oblast]]\n|subdivision_type2      = [[Counties of Russia|County]] \n|subdivision_name2      = \n|subdivision_type3      = [[Districts of Russia|District]] \n|subdivision_name3      = [[Kholmogorsky District]]\n|subdivision_type4      = [[List of municipalities of Russia|Municipality]]\n|subdivision_name4      = \n|timezone1              = \n|utc_offset1            = +3:00\n|timezone1_DST          = \n|utc_offset1_DST        = \n|postal_code_type       = \n|postal_code            = \n|elevation_m            = \n|elevation_footnotes    = \n|coordinates            = {{coord|64|06|N|41|42|E|display=inline}}<ref>[https://mapdata.ru/arhangelskaya-oblast/holmogorskiy-rayon/poselok-malaya-tovra/ \u041a\u0430\u0440\u0442\u0430 \u043f\u043e\u0441\u0435\u043b\u043a\u0430 \u041c\u0430\u043b\u0430\u044f \u0422\u043e\u0432\u0440\u0430 \u0432 \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438]</ref>\n}}\n'''Malaya Tovra''' ({{lang-ru|\u041c\u0430\u043b\u0430\u044f \u0422\u043e\u0432\u0440\u0430}}) is a [[types of inhabited localities in Russia|rural locality]] (a [[Village#Russia|settlement]]) in Matigorskoye Rural Settlement of [[Kholmogorsky District]], [[Arkhangelsk Oblast]], Russia. The population was 138 as of 2010.<ref name=\"arhangelskstat\">{{cite web|url=http://arhangelskstat.gks.ru/wps/wcm/connect/rosstat_ts/arhangelskstat/resources/2edc58004f857ef7ae20af9b972d8349/%D1%87%D0%B8%D1%81%D0%BB%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C.doc|website=arhangelskstat.gks.ru|title=\u0412\u0441\u0435\u0440\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u043f\u0435\u0440\u0435\u043f\u0438\u0441\u044c \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u0438\u044f 2010 \u0433\u043e\u0434\u0430. \u0427\u0438\u0441\u043b\u0435\u043d\u043d\u043e\u0441\u0442\u044c \u043f\u043e \u043c\u0443\u043d\u0438\u0446\u0438\u043f\u0430\u043b\u044c\u043d\u044b\u043c \u043e\u0431\u0440\u0430\u0437\u043e\u0432\u0430\u043d\u0438\u044f\u043c \u0438 \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u043d\u044b\u043c \u043f\u0443\u043d\u043a\u0442\u0430\u043c \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438|accessdate=2019-02-19|archive-url=https://web.archive.org/web/20130927112811/http://arhangelskstat.gks.ru/wps/wcm/connect/rosstat_ts/arhangelskstat/resources/2edc58004f857ef7ae20af9b972d8349/%D1%87%D0%B8%D1%81%D0%BB%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C.doc|archive-date=2013-09-27|url-status=dead}}</ref>\n\n== References ==\n{{reflist}}\n\n{{Rural localities in Kholmogorsky District}}\n{{Authority control}}\n\n[[Category:Rural localities in Arkhangelsk Oblast]]\n[[Category:Rural localities in Kholmogorsky District]]\n\n\n{{ArkhangelskOblast-geo-stub}}\n", "name_user": "Wagino 20100516", "label": "safe", "comment": "\u2192\u200eReferences:clean up", "url_page": "//en.wikipedia.org/wiki/Malaya_Tovra"}
{"title_page": "Mount St. Catherine Forest Reserve", "text_new": "{{Infobox protected area\n| name                = Mount St. Catherine Forest Reserve\n| map                 = Grenada\n| coordinates         = {{coord|12.162281|N|61.675035|W|type:park_scale:100000|display=inline,title}}\n| iucn_category       = \n| photo               = Mt. St. Catherine Forest Reserve limits.jpg\n| photo_width         = \n| photo_alt           = \n| photo_caption      = Reserve limits and summit trails\n| map_width           = \n| nearest_town        = Victoria\n| coords_ref          = \n| area_ha             = 934\n| area_acre           = 2308\n| elevation_max       = 840 m\n| designation         = \n| authorized          = \n| created             = \n| designated          = \n| established         = \n| named_for           = \n| visitation_num      = \n}}\n\n\n\nThe '''Mount St. Catherine Forest Reserve''' is the second largest declared terrestrial [[protected area]] in [[Grenada]] after the [[Grand Etang and Annandale Forest Reserves]].<ref>{{cite web|url=https://www.oas.org/dsd/publications/Unit/oea51e/oea51e.pdf|title=Plan and Policy for a System of National Parks and Protected Areas|author1=Hubber, R. |lastauthoramp=yes |author2=Vincent, G |year=1988}}</ref> Covering {{convert|934|ha|abbr=on}} within a {{convert|31.7|km|abbr=on}} boundary perimeter, its headwaters drain across seven of the largest watersheds on the island and supply important catchment basins for water distribution to Grenadians and agrarian landscapes downstream. The forest reserve encompasses the principal peak of the [[Mount Saint Catherine (Grenada)|Mount Saint Catherine]] massif\u2014the highest point on the island {{convert|840|m|abbr=on}}, as well as other lushly forested ridges and lesser peaks (e.g. Mount Hope), the highest waterfall in the country ([[Tufton Hall Waterfall]]s), the majority of the island's known hot springs, including the hottest geothermal spring (Hapsack Springs) and its most accessible [[geothermal energy|geothermal]] bathing pool (Clabony Sulphur Springs).<ref name=Aucoin>{{cite journal |url=https://www.researchgate.net/publication/327060097_Mount_St_Catherine_Forest_Reserve_Environmental_Baseline_Assessment |author1=Aucoin, S. |lastauthoramp=yes |year=2018 |title=Mount St. Catherine Forest Reserve Environmental Baseline Assessment }}</ref>\n\n==Physical Environment and Ecology==\nThe Mt. St. Catherine [[massif]] is an extensively weathered [[volcano]] that is considered dormant because it has likely not erupted since the last [[Ice Age]].<ref>{{cite web|url=https://pdf.usaid.gov/pdf_docs/pnabh224.pdf|title=Grenada, country environmental profile}}</ref> It is considered to be the only live volcano among the five volcanic centers in Grenada on account of its relatively well-preserved morphology and the presence of [[hot spring]]s and [[fumarole]]s on its flanks.<ref>{{cite web|url=https://volcano.si.edu/volcano.cfm?vn=360170|title=Global Volcanism Program - St. Catherine|publisher=National Museum of Natural History, Smithsonian Institution|date=12 August 2018}}</ref> The forest reserve area is typical of tropical montane [[Cloud Forest|cloud forests]], which develop in areas where clouds impinge almost continuously on tropical mountain vegetation and differ from lowland rainforests in structure (low stature, small and tough leaves, low diversity) and function (low productivity and low nutrient-cycling rates). They are considered highly endangered ecosystems on account that these forest formations are rare, fragile, and are probably disappearing faster than any other forest ecosystem in the neotropics today.<ref name=LaBastille>{{cite journal |author1=LaBastille, A.  |author2=Pool,  D. J.  |lastauthoramp=yes |year=1978 |title=On the Need for a System of Cloud-forest Parks in Middle America and the Caribbean |journal=Environmental Conservation |volume=5 |pages=183\u2013190 |doi=10.1017/S0376892900005890}}</ref>\n<br>\n[[File:Mt. St. Catherine Forest Reserve summit.jpg|thumb|center|500px|Elfin/Sierra palm cloud forest on a clear day on the Mt. St. Catherine summit (840 m). The tower cables are just above the summit exit that leads to Victoriaville seen on the coast to the right]]\n\n{{multiple image\n | direction = Vertical\n | image1 = St. Mark's River, Grenada.jpg\n | width1 = 200\n | caption1 = Transitional and tall cloud forest along the St. Mark's River towards Tufton Hall Waterfalls\n | image2 = Sierra palm, Mt. St. Catherine Forest Reserve, Grenada.jpg\n | width2 = 200\n | caption2 = Sierra palm along the trail towards the forest reserve summit}}\n\nThe Mt. St. Catherine Forest Reserve is further representative of lowland rainforest and lower montane cloud forest,<ref name=Grubb>{{cite journal |author1=Grubb, P. J. |lastauthoramp=yes|year=1971 |title=Interpretation of the 'Massenerhebung' effect on tropical mountains |journal=Nature |volume=229 |pages=44\u201345 |doi=10.1038/229044a0 |pmid=16059069}}</ref> with its highland vegetation of dense tree growth comprising forest formations of Sierra palm, transitional and tall cloud forest, and [[Dwarf forest|Elfin/]]Sierra palm cloud forest,<ref name=Helmer>{{cite journal |author1=Helmer, E. H.| author2=Kennaway, T. A.| author3=Pedreros, D. H.| author4=Clark, M. L.| author5=Marcano-Vega, H.| author6=Tieszen, L. L.| author7=Schill, S. R.| author8=Carrington, C. M. S. |lastauthoramp=yes |year=2008 |title=Land cover and forest formation distributions for St. Kitts, Nevis, St. Eustatius, Grenada and Barbados from decision tree classification of cloud-cleared satellite imagery |journal=Caribbean Journal of Science |volume=44 |pages=175\u2013198}}</ref> laden with [[fern]]s, [[moss]]es and other [[epiphyte]]s and typical stunted woodland growth at higher exposed elevations. In the sheltered lower elevations, the forest is relatively mature, comparable to other rainforests of the island (e.g. Grand Etang and Annandale). [[Secondary forest |Secondary forest growth]] from past cut-over rainforest is apparent surrounding lower supporting ridges and around the periphery of the reserve, with mixed-woody agriculture (particularly, [[agroforestry]] plantations of [[nutmeg]] and [[cacao bean|cacao]]) crossing over the forest reserve boundaries mainly on the sides of the reserve by Victoriaville and Mt. Horne.<ref name=Aucoin />\n<br>\n[[File:Tufton Hall Waterfalls.jpg|thumb|200px|Bottom tier of Tufton Hall Waterfalls in the Mt. St. Catherine Forest Reserve]]\n\nThe cloud-forest ecosystem in the Mt. St. Catherine Forest Reserve is a valuable water resource for Grenada. Significant amounts of rainfall and cloud-mist condensate are collected within its highland forests and dispersed downslope throughout the year. It is critically important to the overall [[Drainage basin|watershed]] regimes on the island as the main rivers and [[tributaries]] with perennial flow in Grenada are relatively small, rainfall is highly seasonal and locally limited, and only about 10% of drinking water for the population is generated through groundwater.<ref>{{cite web|url=https://www.giz.de/de/downloads/2017giz-de-gcf-grenada-esia-esmp.pdf|title=Project for a climate resilient water sector in Grenada}}</ref> The Mt. St. Catherine Forest Reserve, along with other montane areas of the island, provides a range of critical watershed services, including hydrological regulation, flood control, groundwater recharge, water quality enhancement, and soil conservation.<ref name=Sharachchandra>{{cite journal |author1=Sharachchandra, L. |lastauthoramp=yes |year=1978 |title=Watershed services of tropical forests: from hydrology to economic valuation to integrated analysis |journal=Current Opinion in Environmental Sustainability |volume=1 |pages=148\u2013155 |doi=10.1016/j.cosust.2009.10.007}}</ref><ref>{{cite book |last1=Bonell |first1=M. |last2=Bruijnzeel|first2=L. A.|date=2004 |title=Forests, water and people in the humid tropics: Past, present and future hydrological research for integrated land and water management |url=https://www.researchgate.net/profile/LA_Bruijnzeel/publication/234313206_Forests_Water_and_People_in_The_Humid_Tropics/links/5433b7cc0cf2dc341dad9a2d/Forests-Water-and-People-in-The-Humid-Tropics.pdf |location=UK |publisher=Cambridge University Press |page=925 |isbn=0521829534}}</ref>\n\n==Hiking and Trails==\n[https://www.wikiloc.com/wikiloc/map.do?sw=-89.999%2C-179.999&ne=89.999%2C179.999&q=mt.%20st.%20catherine%20forest%20reserve%20trail&fitMapToTrails=1&page=1/ (Summit trails downloadable from Wikiloc)]\n\nHiking in the Mt. St. Catherine Forest Reserve is diverse, including 3 steep rugged routes to the top of the cloud forest and the [[Mount St. Catherine]] summit, recreational strolling areas in scenic agroforestry settings, and challenging river trekking to geothermal features and waterfalls. The trail system leading to the forest reserve and continuing to an extent within limits of the reserve are based on old estate roads and tracks established to service crop production in the past and are generally well maintained (hiking level is easy). These may be considered more of a walk on gentle hills along a hard packed trail over a short distance (1 h or less). The main trails starting at the foot of the mountain towards the summit vary in their levels of difficulty (moderate to difficult, 3+ hours). The moderate sections of these main trails cover steep terrain with lots of elevation gain, at times over rocky and muddy parts, but are generally well worn and free of encumbering vegetation. The difficult sections of these main trails may be technically challenging (e.g. requiring the use of hands) with considerable elevation gain, often over steep rocky and muddy terrain, and would not be completed unless one is in good physical condition. Secondary trails exist off these main trails (only used in hunting) and requires bushwhacking and route-finding skills to navigate.\n\n==References==\n{{Reflist}}\n\n[[Category:Forests]]\n[[Category:Protected areas of the Caribbean]]\n[[Category:Geography of Grenada]]\n", "text_old": "{{Infobox protected area\n| name                = Mount St. Catherine Forest Reserve\n| map                 = Grenada\n| coordinates         = {{coord|12.162281|N|61.675035|W|type:park_scale:100000|display=inline,title}}\n| iucn_category       = \n| photo               = Mt. St. Catherine Forest Reserve limits.jpg\n| photo_width         = \n| photo_alt           = \n| photo_caption      = Reserve limits and summit trails\n| map_width           = \n| nearest_town        = Victoria\n| coords_ref          = \n| area_ha             = 934\n| area_acre           = 2308\n| elevation_max       = 840 m\n| designation         = \n| authorized          = \n| created             = \n| designated          = \n| established         = \n| named_for           = \n| visitation_num      = \n}}\n\n\n\nThe '''Mount St. Catherine Forest Reserve''' is the second largest declared terrestrial [[protected area]] in [[Grenada]] after the [[Grand Etang and Annandale Forest Reserves]].<ref>{{cite web|url=https://www.oas.org/dsd/publications/Unit/oea51e/oea51e.pdf|title=Plan and Policy for a System of National Parks and Protected Areas|author1=Hubber, R. |lastauthoramp=yes |author2=Vincent, G |year=1988}}</ref> Covering {{convert|934|ha|abbr=on}} within a {{convert|31.7|km|abbr=on}} boundary perimeter, its headwaters drain across seven of the largest watersheds on the island and supply important catchment basins for water distribution to Grenadians and agrarian landscapes downstream. The forest reserve encompasses the principal peak of the [[Mount Saint Catherine (Grenada)|Mount Saint Catherine]] massif\u2014the highest point on the island {{convert|840|m|abbr=on}}, as well as other lushly forested ridges and lesser peaks (e.g. Mount Hope), the highest waterfall in the country ([[Tufton Hall Waterfall]]s), the majority of the island's known hot springs, including the hottest geothermal spring (Hapsack Springs) and its most accessible [[geothermal energy|geothermal]] bathing pool (Clabony Sulphur Springs).<ref name=Aucoin>{{cite journal |url=https://www.researchgate.net/publication/327060097_Mount_St_Catherine_Forest_Reserve_Environmental_Baseline_Assessment |author1=Aucoin, S. |lastauthoramp=yes |year=2018 |title=Mount St. Catherine Forest Reserve Environmental Baseline Assessment }}</ref>\n\n==Physical Environment and Ecology==\nThe Mt. St. Catherine [[massif]] is an extensively weathered [[volcano]] that is considered dormant because it has likely not erupted since the last [[Ice Age]].<ref>{{cite web|url=https://pdf.usaid.gov/pdf_docs/pnabh224.pdf|title=Grenada, country environmental profile}}</ref> It is considered to be the only live volcano among the five volcanic centers in Grenada on account of its relatively well-preserved morphology and the presence of [[hot spring]]s and [[fumarole]]s on its flanks.<ref>{{cite web|url=https://volcano.si.edu/volcano.cfm?vn=360170|title=Global Volcanism Program - St. Catherine|publisher=National Museum of Natural History, Smithsonian Institution|date=12 August 2018}}</ref> The forest reserve area is typical of tropical montane [[Cloud Forest|cloud forests]], which develop in areas where clouds impinge almost continuously on tropical mountain vegetation and differ from lowland rainforests in structure (low stature, small and tough leaves, low diversity) and function (low productivity and low nutrient-cycling rates). They are considered highly endangered ecosystems on account that these forest formations are rare, fragile, and are probably disappearing faster than any other forest ecosystem in the neotropics today.<ref name=LaBastille>{{cite journal |author1=LaBastille, A.  |author2=Pool,  D. J.  |lastauthoramp=yes |year=1978 |title=On the Need for a System of Cloud-forest Parks in Middle America and the Caribbean |journal=Environmental Conservation |volume=5 |pages=183\u2013190 |doi=10.1017/S0376892900005890}}</ref>\n<br>\n[[File:Mt. St. Catherine Forest Reserve summit.jpg|thumb|center|500px|Elfin/Sierra palm cloud forest on a clear day on the Mt. St. Catherine summit (840 m). The tower cables are just above the summit exit that leads to Victoriaville seen on the coast to the right]]\n\n{{multiple image\n | direction = Vertical\n | image1 = St. Mark's River, Grenada.jpg\n | width1 = 200\n | caption1 = Transitional and tall cloud forest along the St. Mark's River towards Tufton Hall Waterfalls\n | image2 = Sierra palm, Mt. St. Catherine Forest Reserve, Grenada.jpg\n | width2 = 200\n | caption2 = Sierra palm along the trail towards the forest reserve summit}}\n\nThe Mt. St. Catherine Forest Reserve is further representative of lowland rainforest and lower montane cloud forest,<ref name=Grubb>{{cite journal |author1=Grubb, P. J. |lastauthoramp=yes|year=1971 |title=Interpretation of the 'Massenerhebung' effect on tropical mountains |journal=Nature |volume=229 |pages=44\u201345 |doi=10.1038/229044a0 |pmid=16059069}}</ref> with its highland vegetation of dense tree growth comprising forest formations of Sierra palm, transitional and tall cloud forest, and [[Dwarf forest|Elfin/]]Sierra palm cloud forest,<ref name=Helmer>{{cite journal |author1=Helmer, E. H.| author2=Kennaway, T. A.| author3=Pedreros, D. H.| author4=Clark, M. L.| author5=Marcano-Vega, H.| author6=Tieszen, L. L.| author7=Schill, S. R.| author8=Carrington, C. M. S. |lastauthoramp=yes |year=2008 |title=Land cover and forest formation distributions for St. Kitts, Nevis, St. Eustatius, Grenada and Barbados from decision tree classification of cloud-cleared satellite imagery |journal=Caribbean Journal of Science |volume=44 |pages=175\u2013198}}</ref> laden with [[fern]]s, [[moss]]es and other [[epiphyte]]s and typical stunted woodland growth at higher exposed elevations. In the sheltered lower elevations, the forest is relatively mature, comparable to other rainforests of the island (e.g. Grand Etang and Annandale). [[Secondary forest |Secondary forest growth]] from past cut-over rainforest is apparent surrounding lower supporting ridges and around the periphery of the reserve, with mixed-woody agriculture (particularly, [[agroforestry]] plantations of [[nutmeg]] and [[cacao bean|cacao]]) crossing over the forest reserve boundaries mainly on the sides of the reserve by Victoriaville and Mt. Horne.<ref name=Aucoin />\n<br>\n[[File:Tufton Hall Waterfalls.jpg|thumb|200px|Bottom tier of Tufton Hall Waterfalls in the Mt. St. Catherine Forest Reserve]]\n\nThe cloud-forest ecosystem in the Mt. St. Catherine Forest Reserve is a valuable water resource for Grenada. Significant amounts of rainfall and cloud-mist condensate are collected within its highland forests and dispersed downslope throughout the year. It is critically important to the overall [[Drainage basin|watershed]] regimes on the island as the main rivers and [[tributaries]] with perennial flow in Grenada are relatively small, rainfall is highly seasonal and locally limited, and only about 10% of drinking water for the population is generated through groundwater.<ref>{{cite web|url=https://www.giz.de/de/downloads/2017giz-de-gcf-grenada-esia-esmp.pdf|title=Project for a climate resilient water sector in Grenada}}</ref> The Mt. St. Catherine Forest Reserve, along with other montane areas of the island, provides a range of critical watershed services, including hydrological regulation, flood control, groundwater recharge, water quality enhancement, and soil conservation.<ref name=Sharachchandra>{{cite journal |author1=Sharachchandra, L. |lastauthoramp=yes |year=1978 |title=Watershed services of tropical forests: from hydrology to economic valuation to integrated analysis |journal=Current Opinion in Environmental Sustainability |volume=1 |pages=148\u2013155 |doi=10.1016/j.cosust.2009.10.007}}</ref><ref>{{cite book |last1=Bonell |first1=M. |last2=Bruijnzeel|first2=L. A.|date=2004 |title=Forests, water and people in the humid tropics: Past, present and future hydrological research for integrated land and water management |url=https://www.researchgate.net/profile/LA_Bruijnzeel/publication/234313206_Forests_Water_and_People_in_The_Humid_Tropics/links/5433b7cc0cf2dc341dad9a2d/Forests-Water-and-People-in-The-Humid-Tropics.pdf |location=UK |publisher=Cambridge University Press |page=925 |isbn=0521829534}}</ref>\n\n==Hiking and Trails==\n[https://https://www.wikiloc.com/wikiloc/map.do?sw=-89.9993850%2C-179.999&ne=89.999%2C179.999&q=Mt.%20St.%20Catherine%20Forest%20Reserve%20trail&fitMapToTrails=1&page=1/ (Summit trails downloadable from Wikiloc)]\n\nHiking in the Mt. St. Catherine Forest Reserve is diverse, including 3 steep rugged routes to the top of the cloud forest and the [[Mount St. Catherine]] summit, recreational strolling areas in scenic agroforestry settings, and challenging river trekking to geothermal features and waterfalls. The trail system leading to the forest reserve and continuing to an extent within limits of the reserve are based on old estate roads and tracks established to service crop production in the past and are generally well maintained (hiking level is easy). These may be considered more of a walk on gentle hills along a hard packed trail over a short distance (1 h or less). The main trails starting at the foot of the mountain towards the summit vary in their levels of difficulty (moderate to difficult, 3+ hours). The moderate sections of these main trails cover steep terrain with lots of elevation gain, at times over rocky and muddy parts, but are generally well worn and free of encumbering vegetation. The difficult sections of these main trails may be technically challenging (e.g. requiring the use of hands) with considerable elevation gain, often over steep rocky and muddy terrain, and would not be completed unless one is in good physical condition. Secondary trails exist off these main trails (only used in hunting) and requires bushwhacking and route-finding skills to navigate.\n\n==References==\n{{Reflist}}\n\n[[Category:Forests]]\n[[Category:Protected areas of the Caribbean]]\n[[Category:Geography of Grenada]]\n", "name_user": "Saucoin", "label": "safe", "comment": "\u2192\u200eHiking and Trails", "url_page": "//en.wikipedia.org/wiki/Mount_St._Catherine_Forest_Reserve"}
{"title_page": "List of volcanoes in Costa Rica", "text_new": "{{see also|Lists of volcanoes}}\n<!--This list is split from its main article where many elevations are incorrect--> \n{{GeoGroupTemplate}}\nThis is a list of active and extinct [[volcano]]es in [[Costa Rica]].\n\n{| border=\"1\" cellpadding=\"1\" cellspacing=\"5\" \n|- align=\"center\" bgcolor=\"cccccc\"\n| rowspan=\"2\"|Name ||colspan =\"2\"| Elevation || Location  ||rowspan=\"2\"| Last eruption\n|- align=\"center\" bgcolor=\"cccccc\"\n| meters||feet||[[Geographic coordinates|Coordinates]]\n|- align=\"right\"\n| align=\"left\"| [[Aguas Zarcas Group]]<ref>{{Cite web|url=https://volcano.si.edu/volcano.cfm?vn=345034&vtab=Subfeatures|title=Global Volcanism Program {{!}} Platanar|website=volcano.si.edu|access-date=2016-12-16}}</ref> || || || {{Coord|10.3|-84.366}} || unknown \n|- align=\"right\"\n| align=\"left\"| [[Arenal Volcano|Arenal]] || 1670 || 5479 || {{coord|10.463|N|84.703|W|type:mountain}} || 2010\n|- align=\"right\" \n| align=\"left\"| [[Barva Volcano|Barva]] || 2906 || 9534 || {{coord|10.135|N|84.10|W|type:mountain}} || 6050 BC\n|- align=\"right\"\n| align=\"left\"| [[Chopo Volcano]] (also known as Anunciaci\u00f3n, Coronaci\u00f3n, Asunci\u00f3n)<ref name=\"induni\">{{cite book |last1=Alvarado Induni |first1=Guillermo |title=Los volcanes de Costa Rica |publisher=Editorial de la Universidad Estatal a Distancia |isbn=978-9968-316-79-8 |pages=98-100}}</ref><ref>{{Cite journal|last=Bergoeing|first=Jean Pierre|date=2006-01-01|year=|title=El cuaternario en Costa Rica. Proposici\u00f3n cronol\u00f3gica|url=https://dialnet.unirioja.es/servlet/articulo?codigo=4796367|journal=Reflexiones|language=es|volume=85|issue=1|pages=13|issn=1021-1209|via=}}</ref> || - || - || - ||\n|- align=\"right\"\n| align=\"left\"| [[Cerro Tilar\u00e1n]] <ref>{{cite book|author=Guillermo E. Alvarado Induni|title=Los volcanes de Costa Rica: geolog\u00eda, historia, riqueza natural y su gente|url=https://books.google.com/books?id=U87jyJf2DCsC&pg=PA142|year=2011|publisher=EUNED|isbn=978-9968-31-679-8|page=142}}</ref> || 634 || 2080 || {{coord|10.451|N|84.978|W|type:mountain}} || [[Pleistocene]]\n|- align=\"right\"\n| align=\"left\"| [[Iraz\u00fa Volcano|Iraz\u00fa]] || 3432 || 11,260 || {{coord|9.979|N|83.852|W|type:mountain}} || 1994\n|- align=\"right\"\n| align=\"left\"| [[Laguna Poco Sol]] || 789 || 2589 || {{coord|10.35|N|84.67|W|type:mountain}} ||-\n|- align=\"right\"\n| align=\"left\"| [[Miravalles Volcano|Miravalles]] || 2028 || 6653 || {{coord|10.784|N|85.153|W|type:mountain}} || 1946\n|- align=\"right\"\n| align=\"left\"| [[Oros\u00ed Volcano|Oros\u00ed]] || 1659 || 5443 || {{coord|10.980|N|85.473|W|type:mountain}} || 3500 years ago\n|- align=\"right\"\n| align=\"left\"| [[Platanar]] || 2267 || 7438 || {{coord|10.30|N|84.366|W|type:mountain}} || Holocene\n|- align=\"right\"\n| align=\"left\"| [[Po\u00e1s Volcano|Po\u00e1s]] || 2708 || 8884 || {{coord|10.20|N|84.233|W|type:mountain}} || September 2019<ref> https://ticotimes.net/2019/09/30/poas-volcano-erupts-again-sends-ash-cloud-2-km-into-atmosphere </ref>\n|- align=\"right\"\n| align=\"left\"| [[Rinc\u00f3n de la Vieja Volcano|Rinc\u00f3n de la Vieja]] || 1916 || 6286 || {{coord|10.830|N|85.324|W|type:mountain}} || May 23, 2017\n|- align=\"right\"\n| align=\"left\"| [[Tenorio Volcano|Tenorio]] || 1916 || 6286 || {{coord|10.673|N|85.015|W|type:mountain}} ||-\n|- align=\"right\"\n| align=\"left\"| [[Turrialba Volcano|Turrialba]] || 3340 || 10,958 || {{coord|10.025|N|83.767|W|type:mountain}} || September 2016\n|}\n\n==See also==\n* [[Central America Volcanic Arc]]\n* [[List of volcanoes in El Salvador]]\n* [[List of volcanoes in Guatemala]]\n* [[List of volcanoes in Honduras]]\n* [[List of volcanoes in Nicaragua]]\n* [[List of volcanoes in Panama]]\n\n== References ==\n\n<references />\n{{Global Volcanism Program}}\n*[https://web.archive.org/web/20100208155214/http://www.ovsicori.una.ac.cr/vulcanologia/vulcanologia.htm Vulcanolog\u00eda]. Observatorio Vulcanol\u00f3gico y Sismol\u00f3gico de Costa Rica (OVSICORI).\n\n{{Volcanoes of Costa Rica}}\n{{Central American volcanoes}}\n\n[[Category:Lists of volcanoes|Costa Rica]]\n[[Category:Volcanoes of Costa Rica| ]]\n[[Category:Lists of landforms of Costa Rica|Volcanoes]]\n", "text_old": "{{see also|Lists of volcanoes}}\n<!--This list is split from its main article where many elevations are incorrect--> \n{{GeoGroupTemplate}}\nThis is a list of active and extinct [[volcano]]es in [[Costa Rica]].\n\n{| border=\"1\" cellpadding=\"1\" cellspacing=\"5\" \n|- align=\"center\" bgcolor=\"cccccc\"\n| rowspan=\"2\"|Name ||colspan =\"2\"| Elevation || Location  ||rowspan=\"2\"| Last eruption\n|- align=\"center\" bgcolor=\"cccccc\"\n| meters||feet||[[Geographic coordinates|Coordinates]]\n|- align=\"right\"\n| align=\"left\"| [[Aguas Zarcas Group]]<ref>{{Cite web|url=https://volcano.si.edu/volcano.cfm?vn=345034&vtab=Subfeatures|title=Global Volcanism Program {{!}} Platanar|website=volcano.si.edu|access-date=2016-12-16}}</ref> || || || {{Coord|10.3|-84.366}} || unknown \n|- align=\"right\"\n| align=\"left\"| [[Arenal Volcano|Arenal]] || 1670 || 5479 || {{coord|10.463|N|84.703|W|type:mountain}} || 2010\n|- align=\"right\" \n| align=\"left\"| [[Barva Volcano|Barva]] || 2906 || 9534 || {{coord|10.135|N|84.10|W|type:mountain}} || 6050 BC\n|- align=\"right\"\n| align=\"left\"| [[Chopo Volcano]] (also known as Anunciaci\u00f3n, Coronaci\u00f3n, Asunci\u00f3n)<ref>{{Cite journal|last=Bergoeing|first=Jean Pierre|date=2006-01-01|year=|title=El cuaternario en Costa Rica. Proposici\u00f3n cronol\u00f3gica|url=https://dialnet.unirioja.es/servlet/articulo?codigo=4796367|journal=Reflexiones|language=es|volume=85|issue=1|pages=13|issn=1021-1209|via=}}</ref> || - || - || - ||\n|- align=\"right\"\n| align=\"left\"| [[Cerro Tilar\u00e1n]] <ref>{{cite book|author=Guillermo E. Alvarado Induni|title=Los volcanes de Costa Rica: geolog\u00eda, historia, riqueza natural y su gente|url=https://books.google.com/books?id=U87jyJf2DCsC&pg=PA142|year=2011|publisher=EUNED|isbn=978-9968-31-679-8|page=142}}</ref> || 634 || 2080 || {{coord|10.451|N|84.978|W|type:mountain}} || [[Pleistocene]]\n|- align=\"right\"\n| align=\"left\"| [[Iraz\u00fa Volcano|Iraz\u00fa]] || 3432 || 11,260 || {{coord|9.979|N|83.852|W|type:mountain}} || 1994\n|- align=\"right\"\n| align=\"left\"| [[Laguna Poco Sol]] || 789 || 2589 || {{coord|10.35|N|84.67|W|type:mountain}} ||-\n|- align=\"right\"\n| align=\"left\"| [[Miravalles Volcano|Miravalles]] || 2028 || 6653 || {{coord|10.784|N|85.153|W|type:mountain}} || 1946\n|- align=\"right\"\n| align=\"left\"| [[Oros\u00ed Volcano|Oros\u00ed]] || 1659 || 5443 || {{coord|10.980|N|85.473|W|type:mountain}} || 3500 years ago\n|- align=\"right\"\n| align=\"left\"| [[Platanar]] || 2267 || 7438 || {{coord|10.30|N|84.366|W|type:mountain}} || Holocene\n|- align=\"right\"\n| align=\"left\"| [[Po\u00e1s Volcano|Po\u00e1s]] || 2708 || 8884 || {{coord|10.20|N|84.233|W|type:mountain}} || September 2019<ref> https://ticotimes.net/2019/09/30/poas-volcano-erupts-again-sends-ash-cloud-2-km-into-atmosphere </ref>\n|- align=\"right\"\n| align=\"left\"| [[Rinc\u00f3n de la Vieja Volcano|Rinc\u00f3n de la Vieja]] || 1916 || 6286 || {{coord|10.830|N|85.324|W|type:mountain}} || May 23, 2017\n|- align=\"right\"\n| align=\"left\"| [[Tenorio Volcano|Tenorio]] || 1916 || 6286 || {{coord|10.673|N|85.015|W|type:mountain}} ||-\n|- align=\"right\"\n| align=\"left\"| [[Turrialba Volcano|Turrialba]] || 3340 || 10,958 || {{coord|10.025|N|83.767|W|type:mountain}} || September 2016\n|}\n\n==See also==\n* [[Central America Volcanic Arc]]\n* [[List of volcanoes in El Salvador]]\n* [[List of volcanoes in Guatemala]]\n* [[List of volcanoes in Honduras]]\n* [[List of volcanoes in Nicaragua]]\n* [[List of volcanoes in Panama]]\n\n== References ==\n\n<references />\n{{Global Volcanism Program}}\n*[https://web.archive.org/web/20100208155214/http://www.ovsicori.una.ac.cr/vulcanologia/vulcanologia.htm Vulcanolog\u00eda]. Observatorio Vulcanol\u00f3gico y Sismol\u00f3gico de Costa Rica (OVSICORI).\n\n{{Volcanoes of Costa Rica}}\n{{Central American volcanoes}}\n\n[[Category:Lists of volcanoes|Costa Rica]]\n[[Category:Volcanoes of Costa Rica| ]]\n[[Category:Lists of landforms of Costa Rica|Volcanoes]]\n", "name_user": "Roqz", "label": "safe", "comment": "", "url_page": "//en.wikipedia.org/wiki/List_of_volcanoes_in_Costa_Rica"}
{"title_page": "Lysitsa", "text_new": "{{Infobox settlement\n|official_name          = Lysitsa\n|other_name             = \n|native_name            = \u041b\u044b\u0441\u0438\u0446\u0430\n|nickname               = \n|settlement_type        = Village\n|image_skyline          = \n|image_caption          = \n|pushpin_map            = Russia Arkhangelsk Oblast#Russia\n|pushpin_label_position = \n|pushpin_mapsize        =\n|pushpin_map_caption    = \n|subdivision_type       = Country\n|subdivision_name       = [[Russia]]\n|subdivision_type1      = [[List of regions of Russia|Region]] \n|subdivision_name1      = [[Arkhangelsk Oblast]]\n|subdivision_type2      = [[Counties of Russia|County]] \n|subdivision_name2      = \n|subdivision_type3      = [[Districts of Russia|District]] \n|subdivision_name3      = [[Kholmogorsky District]]\n|subdivision_type4      = [[List of municipalities of Russia|Municipality]]\n|subdivision_name4      = \n|timezone1              = \n|utc_offset1            = +3:00\n|timezone1_DST          = \n|utc_offset1_DST        = \n|postal_code_type       = \n|postal_code            = \n|elevation_m            = \n|elevation_footnotes    = \n|coordinates            = {{coord|63|35|N|41|45|E|display=inline}}<ref>[https://mapdata.ru/arhangelskaya-oblast/holmogorskiy-rayon/derevnya-lisica/ \u041a\u0430\u0440\u0442\u0430 \u0434\u0435\u0440\u0435\u0432\u043d\u0438 \u041b\u044b\u0441\u0438\u0446\u0430 \u0432 \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438]</ref>\n}}\n'''Lysitsa''' ({{lang-ru|\u041b\u044b\u0441\u0438\u0446\u0430}}) is a [[types of inhabited localities in Russia|rural locality]] (a [[Village#Russia|village]]) in Yemetskoye Rural Settlement of [[Kholmogorsky District]], [[Arkhangelsk Oblast]], Russia. The population was 25 as of 2010.<ref name=\"arhangelskstat\">{{cite web|url=http://arhangelskstat.gks.ru/wps/wcm/connect/rosstat_ts/arhangelskstat/resources/2edc58004f857ef7ae20af9b972d8349/%D1%87%D0%B8%D1%81%D0%BB%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C.doc|website=arhangelskstat.gks.ru|title=\u0412\u0441\u0435\u0440\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u043f\u0435\u0440\u0435\u043f\u0438\u0441\u044c \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u0438\u044f 2010 \u0433\u043e\u0434\u0430. \u0427\u0438\u0441\u043b\u0435\u043d\u043d\u043e\u0441\u0442\u044c \u043f\u043e \u043c\u0443\u043d\u0438\u0446\u0438\u043f\u0430\u043b\u044c\u043d\u044b\u043c \u043e\u0431\u0440\u0430\u0437\u043e\u0432\u0430\u043d\u0438\u044f\u043c \u0438 \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u043d\u044b\u043c \u043f\u0443\u043d\u043a\u0442\u0430\u043c \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438|accessdate=2019-02-19|archive-url=https://web.archive.org/web/20130927112811/http://arhangelskstat.gks.ru/wps/wcm/connect/rosstat_ts/arhangelskstat/resources/2edc58004f857ef7ae20af9b972d8349/%D1%87%D0%B8%D1%81%D0%BB%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C.doc|archive-date=2013-09-27|url-status=dead}}</ref>\n\n== References ==\n{{reflist}}\n\n{{Rural localities in Kholmogorsky District}}\n{{Authority control}}\n\n[[Category:Rural localities in Arkhangelsk Oblast]]\n[[Category:Rural localities in Kholmogorsky District]]\n\n{{ArkhangelskOblast-geo-stub}}\n", "text_old": "{{Infobox settlement\n|official_name          = Lysitsa\n|other_name             = \n|native_name            = \u041b\u044b\u0441\u0438\u0446\u0430\n|nickname               = \n|settlement_type        = Village\n|image_skyline          = \n|image_caption          = \n|pushpin_map            = Russia Arkhangelsk Oblast#Russia\n|pushpin_label_position = \n|pushpin_mapsize        =\n|pushpin_map_caption    = \n|subdivision_type       = Country\n|subdivision_name       = [[Russia]]\n|subdivision_type1      = [[List of regions of Russia|Region]] \n|subdivision_name1      = [[Arkhangelsk Oblast]]\n|subdivision_type2      = [[Counties of Russia|County]] \n|subdivision_name2      = \n|subdivision_type3      = [[Districts of Russia|District]] \n|subdivision_name3      = [[Kholmogorsky District]]\n|subdivision_type4      = [[List of municipalities of Russia|Municipality]]\n|subdivision_name4      = \n|timezone1              = \n|utc_offset1            = +3:00\n|timezone1_DST          = \n|utc_offset1_DST        = \n|postal_code_type       = \n|postal_code            = \n|elevation_m            = \n|elevation_footnotes    = \n|coordinates            = {{coord|63|35|N|41|45|E|display=inline}}<ref>[https://mapdata.ru/arhangelskaya-oblast/holmogorskiy-rayon/derevnya-lisica/ \u041a\u0430\u0440\u0442\u0430 \u0434\u0435\u0440\u0435\u0432\u043d\u0438 \u041b\u044b\u0441\u0438\u0446\u0430 \u0432 \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438]</ref>\n}}\n'''Lysitsa''' ({{lang-ru|\u041b\u044b\u0441\u0438\u0446\u0430}}) is a [[types of inhabited localities in Russia|rural locality]] (a [[Village#Russia|village]]) in Yemetskoye Rural Settlement of [[Kholmogorsky District]], [[Arkhangelsk Oblast]], Russia. The population was 25 as of 2010.<ref name=\"arhangelskstat\">{{cite web|url=http://arhangelskstat.gks.ru/wps/wcm/connect/rosstat_ts/arhangelskstat/resources/2edc58004f857ef7ae20af9b972d8349/%D1%87%D0%B8%D1%81%D0%BB%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C.doc|website=arhangelskstat.gks.ru|title=\u0412\u0441\u0435\u0440\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u043f\u0435\u0440\u0435\u043f\u0438\u0441\u044c \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u0438\u044f 2010 \u0433\u043e\u0434\u0430. \u0427\u0438\u0441\u043b\u0435\u043d\u043d\u043e\u0441\u0442\u044c \u043f\u043e \u043c\u0443\u043d\u0438\u0446\u0438\u043f\u0430\u043b\u044c\u043d\u044b\u043c \u043e\u0431\u0440\u0430\u0437\u043e\u0432\u0430\u043d\u0438\u044f\u043c \u0438 \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u043d\u044b\u043c \u043f\u0443\u043d\u043a\u0442\u0430\u043c \u0410\u0440\u0445\u0430\u043d\u0433\u0435\u043b\u044c\u0441\u043a\u043e\u0439 \u043e\u0431\u043b\u0430\u0441\u0442\u0438|accessdate=2019-02-19|archive-url=https://web.archive.org/web/20130927112811/http://arhangelskstat.gks.ru/wps/wcm/connect/rosstat_ts/arhangelskstat/resources/2edc58004f857ef7ae20af9b972d8349/%D1%87%D0%B8%D1%81%D0%BB%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C.doc|archive-date=2013-09-27|url-status=dead}}</ref>\n\n== References ==\n{{reflist}}\n\n{{Rural localities in Kholmogorsky District}}\n{{Authority control}}\n\n[[Category:Rural localities in Arkhangelsk Oblast]]\n[[Category:Rural localities in Kholmogorsky District]]\n\n\n{{ArkhangelskOblast-geo-stub}}\n", "name_user": "Wagino 20100516", "label": "safe", "comment": "\u2192\u200eReferences:clean up", "url_page": "//en.wikipedia.org/wiki/Lysitsa"}
{"title_page": "Boyfriend (Selena Gomez song)", "text_new": "{{short description|2020 single by Selena Gomez}}\n{{Use American English|date=April 2020}}\n{{Use mdy dates|date=April 2020}}\n{{Infobox song\n| name       = Boyfriend\n| type       = single\n| cover      = \n| caption    = \n| artist     = [[Selena Gomez]]\n| album      = [[Rare (Selena Gomez album)|Rare]]\n| released   = {{Start date|2020|04|09|mf=yes}}\n| format     =\n* [[Music download|Digital download]]\n* [[Streaming media|streaming]]\n| recorded   = November 19, 2019\n| genre      = [[House music|House]]\n| length     = {{Duration|m=2|s=41}}\n| label      = [[Interscope Records|Interscope]]\n| writer     =\n* [[Selena Gomez]]\n* [[Julia Michaels]]\n* [[Justin Tranter]]\n* Jon Wienner\n* Sam Homaee\n| producer   = <!-- Do not include those listed as executive, co-, additional, vocal, etc., producers, unless a reliable source identifies their contribution as substantially the same as the main producers, per [[Template:Infobox song#producer]]. -->The Roommates\n| prev_title = [[Rare (Selena Gomez song)|Rare]]\n| prev_year  = 2020\n| next_title = \n| next_year  =\n| misc       = {{External music video|{{YouTube|tSIk1QvIM2E|\"Boyfriend\"}}}}}}\n\n\"'''Boyfriend'''\" is a song by American singer [[Selena Gomez]], included on the deluxe edition of her third [[studio album]] ''[[Rare (Selena Gomez album)|Rare]]'' (2020). The song was released as the first single from the deluxe edition and fourth overall from the album on April 9, 2020.\n\n==Background==\nGomez wrote \"Boyfriend\" after having a text conversation with co-writer [[Julia Michaels]], where Gomez wrote \"I want a boyfriend.\"<ref>{{cite web|url=https://www.billboard.com/articles/columns/pop/9355755/selena-gomez-writing-boyfriend-apple-music-interview|title=Selena Gomez's New Song 'Boyfriend' Was Born From a Text Message|last=Rowley|first=Glenn|date=April 10, 2020|website=[[Billboard (magazine)|Billboard]]|accessdate=April 11, 2020}}</ref> Gomez first revealed the song in an interview on ''[[The Tonight Show Starring Jimmy Fallon]]'' on January 14, 2020, where she said it was an unreleased song from ''Rare''.<ref>{{cite web|url=https://www.youtube.com/watch?v=f7TCzxOS6H4|title=Selena Gomez Reacts to Wizards of Waverly Place Theme Inspiring Billie Eilish's \"Bad Guy\"|last=[[The Tonight Show Starring Jimmy Fallon]]|date=January 14, 2020|website=[[YouTube]]|accessdate=April 9, 2020}}</ref> She later announced the song would appear on the deluxe edition of ''Rare'' on April 6, 2020.<ref>{{Cite tweet |user=selenagomez |number=1247255304196067329 |title=The deluxe version of Rare, featuring 'Boyfriend,' 'She' and 'Souvenir,' is out April 9th. You can presave it now and learn more about how to donate to the PLUS1 COVID-19 Fund in at the link in my bio. \ud83c\udf39 |date=April 6, 2020 |accessdate=April 9, 2020}}</ref> The next day she teased the song's lyrics \"There's a difference between a want and a need. Some nights I just want more than me\" on social media.<ref>{{Cite tweet |user=selenagomez |number=1247616361775239168 |title=There\u2019s a difference between a want and a need. Some nights I just want more than me|date=April 7, 2020 |accessdate=April 9, 2020}}</ref> She wrote about the song's background saying:\n<blockquote>\nMany of you know how excited I have been to release a song called 'Boyfriend.' It's a lighthearted song about falling down and getting back up time and time again in love, but also knowing that you don't need anyone other than yourself to be happy. We wrote it long before our current crisis, but in the context of today, I want to be clear that a boyfriend is nowhere near the top of my list of priorities. Just like the rest of the world, I'm praying for safety, unity and recovery during this [[2019\u201320 coronavirus pandemic|pandemic]].<ref>{{cite web|url=https://www.billboard.com/articles/columns/pop/9352767/selena-gomez-deluxe-edition-rare-stream|title=Selena Gomez Unveils Deluxe Edition of 'Rare' With Three Unreleased Tracks: Listen|last=Kaufman|first=Gil|date=April 9, 2020|website=[[Billboard (magazine)|Billboard]]|accessdate=April 9, 2020}}</ref>\n</blockquote>\n\n==Composition==\nThe song follows a [[house music|house]] beat.<ref>{{cite web|url=http://www.mtv.com/news/3162682/selena-gomez-rare-deluxe-edition-boyfriend-souvenir-she/|title=Selena Gomez's Three New Rare Songs: Breaking Down The Fresh Bops|last=Roth|first=Madeline|date=April 9, 2020|website=[[MTV]]|accessdate=April 11, 2020}}</ref> In terms of [[musical notation|music notation]], \"Boyfriend\" was composed using [[Time signature|{{Time signature|4|4}} common time]] in the [[Key (music)|key]] of [[D major]], with a [[tempo]] of 90 [[beats per minute]].<ref name=\"Musicnotes\">{{cite web|url=https://www.musicnotes.com/sheetmusic/mtd.asp?ppn=MN0209895|title=Selena Gomez \"Boyfriend\" Sheet Music in D Major|publisher=Musicnotes.com|access-date=April 11, 2020}}</ref> Gomez's vocal range spans from the low note G{{music|sharp}}3 to the high note of E5.<ref name=\"Musicnotes\" />\n\n==Music video==\nThe song's official music video premiered on [[YouTube]] on April 10, 2020.<ref>{{cite web|url=https://www.rollingstone.com/music/music-news/selena-gomez-boyfriend-video-981764/|title=Selena Gomez Endures Endless Bad Dates in Twisty \u2018Boyfriend\u2019 Video|last=Spanos|first=Brittany|date=April 10, 2020|website=[[Rolling Stone]]|accessdate=April 11, 2020}}</ref> It was directed by Matty Peacock.<ref>{{cite web|url=https://www.billboard.com/articles/columns/pop/9354916/selena-gomez-boyfriend-video|title=Selena Gomez's 'Boyfriend' Video Involves a Bunch of Frogs and It's Pure Art|last=Rowley|first=Glenn|date=April 10, 2020|website=[[Billboard (magazine)|Billboard]]|accessdate=April 11, 2020}}</ref>\n\n==Credits and personnel==\nCredits adapted from [[Tidal (service)|Tidal]].<ref>{{cite web|url=https://listen.tidal.com/album/136940126/credits|title=Credits / Rare (Deluxe) / Selena Gomez - TIDAL|website=[[Tidal (service)|Tidal]]|accessdate=April 9, 2020}}</ref>\n{{div col}}\n* [[Selena Gomez]] \u2013 vocals, songwriting \n* The Roommates \u2013 production, vocal production, percussion\n* [[Julia Michaels]] \u2013 songwriting, backing vocals\n* [[Justin Tranter]] \u2013 songwriting\n* Jon Wienner \u2013 songwriting, recording, studio personnel\n* Sam Homaee \u2013 songwriting, synthesizer\n* Bart Schoudel \u2013 vocal production\n* Will Quinnell \u2013 assistant mastering engineer, studio personnel\n* [[Chris Gehringer]] \u2013 mastering, studio personnel\n* Miles Comaskey \u2013 mix engineer, studio personnel\n* [[Tony Maserati]] \u2013 mixing, studio personnel\n{{div col end}}\n\n==Release history==\n{| class=\"wikitable plainrowheaders\"\n! scope=\"col\"| Region\n! scope=\"col\"| Date\n! scope=\"col\"| Format\n! scope=\"col\"| Label\n! scope=\"col\"| {{abbr|Ref.|Reference}}\n|-\n! scope=\"row\"| Various\n| April 9, 2020\n| {{hlist|[[Music download|Digital download]]|[[Streaming media|streaming]]}}\n| [[Interscope Records|Interscope]]\n| style=\"text-align:center;\"| <ref>{{cite web|title=Rare (Deluxe) by Selena Gomez|url=https://music.apple.com/us/album/rare-deluxe/1506661706|website=[[Apple Music]]|accessdate=April 9, 2020}}</ref>\n|}\n\n==References==\n{{reflist}}\n\n{{Selena Gomez}}\n[[Category:2020 singles]]\n[[Category:2020 songs]]\n[[Category:Selena Gomez songs]]\n[[Category:Songs written by Julia Michaels]]\n[[Category:Songs written by Justin Tranter]]\n", "text_old": "{{short description|2020 single by Selena Gomez}}\n{{Use American English|date=April 2020}}\n{{Use mdy dates|date=April 2020}}\n{{Infobox song\n| name       = Boyfriend\n| type       = single\n| cover      = \n| caption    = \n| artist     = [[Selena Gomez]]\n| album      = [[Rare (Selena Gomez album)|Rare]]\n| released   = {{Start date|2020|04|09|mf=yes}}\n| format     =\n* [[Music download|Digital download]]\n* [[Streaming media|streaming]]\n| recorded   = November 19, 2019\n| genre      = [[House]]\n| length     = {{Duration|m=2|s=41}}\n| label      = [[Interscope Records|Interscope]]\n| writer     =\n* [[Selena Gomez]]\n* [[Julia Michaels]]\n* [[Justin Tranter]]\n* Jon Wienner\n* Sam Homaee\n| producer   = <!-- Do not include those listed as executive, co-, additional, vocal, etc., producers, unless a reliable source identifies their contribution as substantially the same as the main producers, per [[Template:Infobox song#producer]]. -->The Roommates\n| prev_title = [[Rare (Selena Gomez song)|Rare]]\n| prev_year  = 2020\n| next_title = \n| next_year  =\n| misc       = {{External music video|{{YouTube|tSIk1QvIM2E|\"Boyfriend\"}}}}}}\n\n\"'''Boyfriend'''\" is a song by American singer [[Selena Gomez]], included on the deluxe edition of her third [[studio album]] ''[[Rare (Selena Gomez album)|Rare]]'' (2020). The song was released as the first single from the deluxe edition and fourth overall from the album on April 9, 2020.\n\n==Background==\nGomez wrote \"Boyfriend\" after having a text conversation with co-writer [[Julia Michaels]], where Gomez wrote \"I want a boyfriend.\"<ref>{{cite web|url=https://www.billboard.com/articles/columns/pop/9355755/selena-gomez-writing-boyfriend-apple-music-interview|title=Selena Gomez's New Song 'Boyfriend' Was Born From a Text Message|last=Rowley|first=Glenn|date=April 10, 2020|website=[[Billboard (magazine)|Billboard]]|accessdate=April 11, 2020}}</ref> Gomez first revealed the song in an interview on ''[[The Tonight Show Starring Jimmy Fallon]]'' on January 14, 2020, where she said it was an unreleased song from ''Rare''.<ref>{{cite web|url=https://www.youtube.com/watch?v=f7TCzxOS6H4|title=Selena Gomez Reacts to Wizards of Waverly Place Theme Inspiring Billie Eilish's \"Bad Guy\"|last=[[The Tonight Show Starring Jimmy Fallon]]|date=January 14, 2020|website=[[YouTube]]|accessdate=April 9, 2020}}</ref> She later announced the song would appear on the deluxe edition of ''Rare'' on April 6, 2020.<ref>{{Cite tweet |user=selenagomez |number=1247255304196067329 |title=The deluxe version of Rare, featuring 'Boyfriend,' 'She' and 'Souvenir,' is out April 9th. You can presave it now and learn more about how to donate to the PLUS1 COVID-19 Fund in at the link in my bio. \ud83c\udf39 |date=April 6, 2020 |accessdate=April 9, 2020}}</ref> The next day she teased the song's lyrics \"There's a difference between a want and a need. Some nights I just want more than me\" on social media.<ref>{{Cite tweet |user=selenagomez |number=1247616361775239168 |title=There\u2019s a difference between a want and a need. Some nights I just want more than me|date=April 7, 2020 |accessdate=April 9, 2020}}</ref> She wrote about the song's background saying:\n<blockquote>\nMany of you know how excited I have been to release a song called 'Boyfriend.' It's a lighthearted song about falling down and getting back up time and time again in love, but also knowing that you don't need anyone other than yourself to be happy. We wrote it long before our current crisis, but in the context of today, I want to be clear that a boyfriend is nowhere near the top of my list of priorities. Just like the rest of the world, I'm praying for safety, unity and recovery during this [[2019\u201320 coronavirus pandemic|pandemic]].<ref>{{cite web|url=https://www.billboard.com/articles/columns/pop/9352767/selena-gomez-deluxe-edition-rare-stream|title=Selena Gomez Unveils Deluxe Edition of 'Rare' With Three Unreleased Tracks: Listen|last=Kaufman|first=Gil|date=April 9, 2020|website=[[Billboard (magazine)|Billboard]]|accessdate=April 9, 2020}}</ref>\n</blockquote>\n\n==Composition==\nThe song follows a [[house music|house]] beat.<ref>{{cite web|url=http://www.mtv.com/news/3162682/selena-gomez-rare-deluxe-edition-boyfriend-souvenir-she/|title=Selena Gomez's Three New Rare Songs: Breaking Down The Fresh Bops|last=Roth|first=Madeline|date=April 9, 2020|website=[[MTV]]|accessdate=April 11, 2020}}</ref> In terms of [[musical notation|music notation]], \"Boyfriend\" was composed using [[Time signature|{{Time signature|4|4}} common time]] in the [[Key (music)|key]] of [[D major]], with a [[tempo]] of 90 [[beats per minute]].<ref name=\"Musicnotes\">{{cite web|url=https://www.musicnotes.com/sheetmusic/mtd.asp?ppn=MN0209895|title=Selena Gomez \"Boyfriend\" Sheet Music in D Major|publisher=Musicnotes.com|access-date=April 11, 2020}}</ref> Gomez's vocal range spans from the low note G{{music|sharp}}3 to the high note of E5.<ref name=\"Musicnotes\" />\n\n==Music video==\nThe song's official music video premiered on [[YouTube]] on April 10, 2020.<ref>{{cite web|url=https://www.rollingstone.com/music/music-news/selena-gomez-boyfriend-video-981764/|title=Selena Gomez Endures Endless Bad Dates in Twisty \u2018Boyfriend\u2019 Video|last=Spanos|first=Brittany|date=April 10, 2020|website=[[Rolling Stone]]|accessdate=April 11, 2020}}</ref> It was directed by Matty Peacock.<ref>{{cite web|url=https://www.billboard.com/articles/columns/pop/9354916/selena-gomez-boyfriend-video|title=Selena Gomez's 'Boyfriend' Video Involves a Bunch of Frogs and It's Pure Art|last=Rowley|first=Glenn|date=April 10, 2020|website=[[Billboard (magazine)|Billboard]]|accessdate=April 11, 2020}}</ref>\n\n==Credits and personnel==\nCredits adapted from [[Tidal (service)|Tidal]].<ref>{{cite web|url=https://listen.tidal.com/album/136940126/credits|title=Credits / Rare (Deluxe) / Selena Gomez - TIDAL|website=[[Tidal (service)|Tidal]]|accessdate=April 9, 2020}}</ref>\n{{div col}}\n* [[Selena Gomez]] \u2013 vocals, songwriting \n* The Roommates \u2013 production, vocal production, percussion\n* [[Julia Michaels]] \u2013 songwriting, backing vocals\n* [[Justin Tranter]] \u2013 songwriting\n* Jon Wienner \u2013 songwriting, recording, studio personnel\n* Sam Homaee \u2013 songwriting, synthesizer\n* Bart Schoudel \u2013 vocal production\n* Will Quinnell \u2013 assistant mastering engineer, studio personnel\n* [[Chris Gehringer]] \u2013 mastering, studio personnel\n* Miles Comaskey \u2013 mix engineer, studio personnel\n* [[Tony Maserati]] \u2013 mixing, studio personnel\n{{div col end}}\n\n==Release history==\n{| class=\"wikitable plainrowheaders\"\n! scope=\"col\"| Region\n! scope=\"col\"| Date\n! scope=\"col\"| Format\n! scope=\"col\"| Label\n! scope=\"col\"| {{abbr|Ref.|Reference}}\n|-\n! scope=\"row\"| Various\n| April 9, 2020\n| {{hlist|[[Music download|Digital download]]|[[Streaming media|streaming]]}}\n| [[Interscope Records|Interscope]]\n| style=\"text-align:center;\"| <ref>{{cite web|title=Rare (Deluxe) by Selena Gomez|url=https://music.apple.com/us/album/rare-deluxe/1506661706|website=[[Apple Music]]|accessdate=April 9, 2020}}</ref>\n|}\n\n==References==\n{{reflist}}\n\n{{Selena Gomez}}\n[[Category:2020 singles]]\n[[Category:2020 songs]]\n[[Category:Selena Gomez songs]]\n[[Category:Songs written by Julia Michaels]]\n[[Category:Songs written by Justin Tranter]]\n", "name_user": "Bodhisattvasud", "label": "safe", "comment": "genre", "url_page": "//en.wikipedia.org/wiki/Boyfriend_(Selena_Gomez_song)"}
{"title_page": "Ivermectin", "text_new": "{{Use mdy dates|date=May 2016}}\n{{Use American English|date=May 2016}}\n{{Drugbox\n| Verifiedfields = changed\n| Watchedfields = changed\n| verifiedrevid = 457127811\n| IUPAC_name = 22,23-dihydroavermectin B<sub>1a</sub> + 22,23-dihydroavermectin B<sub>1b</sub>\n| image = Ivermectin skeletal.svg\n| width = 300\n\n<!--Clinical data-->\n| tradename = Stromectol, Soolantra cream\n| Drugs.com = {{drugs.com|monograph|ivermectin}} ([[antiparasitic]])<br />{{Drugs.com|pro|soolantra-cream}} ([[rosacea]])\n| MedlinePlus = a607069\n| DailyMedID = Ivermectin\n| pregnancy_AU = B3\n| pregnancy_US = C\n| legal_US = Rx-only\n| routes_of_administration = By mouth, topical\n| ATC_prefix = D11\n| ATC_suffix = AX22\n| ATC_supplemental = {{ATC|P02|CF01}} {{ATCvet|P54|AA01}} {{ATCvet|S02|QA03}}\n\n<!--Pharmacokinetic data-->\n| bioavailability =\n| protein_bound = 93%\n| metabolism = Liver ([[CYP450]])\n| elimination_half-life = 18 hours\n| excretion = Feces; <1% urine\n\n<!--Identifiers-->\n| CAS_number_Ref = {{cascite|correct|??}}\n| CAS_number = 70288-86-7\n| CAS_supplemental = {{CAS|71827-03-7}}\n| PubChem = 9812710\n| DrugBank_Ref = {{drugbankcite|correct|drugbank}}\n| DrugBank = DB00602\n| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}\n| ChemSpiderID = 7988461\n| UNII_Ref = {{fdacite|correct|FDA}}\n| UNII = 8883YP2R6D\n| KEGG_Ref = {{keggcite|correct|kegg}}\n| KEGG = D00804\n| ChEMBL_Ref = {{ebicite|changed|EBI}}\n| ChEMBL = 341047\n| PDB_ligand = IVM\n\n<!--Chemical data-->\n| chemical_formula = {{Chem | C|48 | H|74 | O|14}} {{nowrap|1=(22,23-dihydroavermectin&nbsp;B<sub>1a</sub>)}}<br />{{Chem | C|47 | H|72 | O|14}} {{nowrap|1=(22,23-dihydroavermectin&nbsp;B<sub>1b</sub>)}}\n| molecular_weight = 875.10 g/mol\n| StdInChI_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChI = 1S/C48H74O14.C47H72O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38;1-24(2)41-27(5)16-17-46(61-41)22-33-19-32(60-46)15-14-26(4)42(25(3)12-11-13-31-23-54-44-39(48)28(6)18-34(45(50)57-33)47(31,44)51)58-38-21-36(53-10)43(30(8)56-38)59-37-20-35(52-9)40(49)29(7)55-37/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3;11-14,18,24-25,27,29-30,32-44,48-49,51H,15-17,19-23H2,1-10H3/b13-12+,27-15+,32-14+;12-11+,26-14+,31-13+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+;25-,27-,29-,30-,32+,33-,34-,35-,36-,37-,38-,39+,40-,41+,42-,43-,44+,46+,47+/m00/s1\n| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChIKey = SPBDXSGPUHCETR-JFUDTMANSA-N\n| smiles = CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C.C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)O[C@@H]1C(C)C\n}}\n<!-- Definition and medical uses -->\n'''ivermectin''' brand sold name '''[https://www.amirhealthcare.com/ivermectin-6mg-ivermite-oral-uses-side-effects-dose-in-urdu/ ivermite]'''is used for Scabies cost camparable cheapest than topical agent for the treatment of Scabies\n'''Ivermectin''' is a medication used to treat many types of [[parasite]] infestations.<ref name=AHFS2016/> This includes [[head lice infestation|head lice]], [[scabies]], [[onchocerciasis|river blindness]] (onchocerciasis), [[strongyloidiasis]], [[trichuriasis]], [[ascariasis]], and [[lymphatic filariasis]].<ref name=AHFS2016/><ref>{{cite book |last1=Sneader |first1=Walter | name-list-format = vanc |title=Drug Discovery a History.|date=2005|publisher=John Wiley & Sons|location=Chichester|isbn=978-0-470-01552-0|page=333|url=https://books.google.com/books?id=jglFsz5EJR8C&pg=PA333}}</ref><ref name=Sau2015/><ref>{{cite web | author = CDC-Centers for Disease Control and Prevention |title= Ascariasis - Resources for Health Professionals |url= https://www.cdc.gov/parasites/ascariasis/health_professionals/index.html |website=www.cdc.gov |accessdate=28 December 2019 |language=en-us |date=23 August 2019}}</ref> It can be taken by mouth or applied to the skin for external infestations.<ref name=AHFS2016/><ref>{{cite journal | vauthors = Panahi Y, Poursaleh Z, Goldust M |url= https://www.annals-parasitology.eu/go.live.php/download_default/D660/2015-61-1_11.pdf | title = The efficacy of topical and oral ivermectin in the treatment of human scabies | journal = Annals of Parasitology | volume = 61 | issue = 1 | pages = 11\u201316 | date = 2015 | pmid = 25911032 }}</ref> Use in the eyes should be avoided.<ref name=AHFS2016 />\n\n<!-- Side effects and mechanism -->\nCommon side effects include [[Red eye (medicine)|red eyes]], dry skin, and burning skin.<ref name=AHFS2016>{{cite web|title=Ivermectin|url=https://www.drugs.com/monograph/ivermectin.html|publisher=The American Society of Health-System Pharmacists|access-date=16 January 2016|url-status=live|archive-url=https://web.archive.org/web/20160103191914/http://www.drugs.com/monograph/ivermectin.html|archive-date=January 3, 2016|df=mdy-all}}</ref> It is unclear if it is safe for use during [[pregnancy]], but is probably acceptable for use during [[breastfeeding]].<ref>{{cite web |title = Ivermectin Levels and Effects while Breastfeeding |url= https://www.drugs.com/breastfeeding/ivermectin.html | work = Drugs.com |access-date=January 16, 2016 |url-status=live |archive-url= https://web.archive.org/web/20160101113118/http://www.drugs.com/breastfeeding/ivermectin.html |archive-date=January 1, 2016|df=mdy-all}}</ref> It belongs to the [[avermectin]] family of medications.<ref name=AHFS2016 /> It works by causing the parasite's [[cell membrane]] to increase in [[Semipermeable membrane|permeability]], resulting in paralysis and death.<ref name=AHFS2016/>\n\n<!-- Society and culture -->\nIvermectin was discovered in 1975 and came into medical use in 1981.<ref name=Meh2008>{{cite book |last1=Mehlhorn |first1=Heinz | name-list-format = vanc |title=Encyclopedia of parasitology |date=2008 |publisher=Springer |location=Berlin |isbn=978-3-540-48994-8 |page=646 |edition=3rd |url=https://books.google.com/books?id=Jpg1ysgVn-AC&pg=PA646 |url-status=live |archive-url=https://web.archive.org/web/20160131155507/https://books.google.com/books?id=Jpg1ysgVn-AC&pg=PA646 |archive-date=January 31, 2016 |df=mdy-all}}</ref><ref>{{cite book| veditors = Vercruysse J, Rew RS |title=Macrocyclic lactones in antiparasitic therapy|date=2002|publisher=CABI Pub.|location=Oxon, UK|isbn=978-0-85199-840-4|page=Preface|url=https://books.google.com/books?id=QXafQ91O74wC&pg=PR13|url-status=live|archive-url=https://web.archive.org/web/20160131121128/https://books.google.com/books?id=QXafQ91O74wC&pg=PR13|archive-date=January 31, 2016|df=mdy-all}}</ref> It is on the [[WHO Model List of Essential Medicines|World Health Organization's List of Essential Medicines]].<ref name=\"WHO21st\">{{cite book | vauthors = ((World Health Organization)) | title = World Health Organization model list of essential medicines: 21st list 2019 | year = 2019 | hdl = 10665/325771 | author-link = World Health Organization | publisher = World Health Organization | location = Geneva | id = WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO | hdl-access=free }}</ref> The wholesale cost in the [[developing world]] for the tablets is about US$0.12 for a course of treatment.<ref name=MSH2014>{{cite web|title=Ivermectin|url=https://www.msh.org/resources/international-medical-products-price-guide?DMFId=1376&searchYear=2014 |website=International Medical Products Price Guide|access-date=April 6, 2020}}</ref> In the United States, the costs is less than US$50.<ref name=Ric2014>{{cite book |last1=Hamilton |first1=Richard J. | name-list-format = vanc |title=Tarascon pocket pharmacopoeia : 2014 deluxe lab-pocket edition|date=2014|publisher=Jones & Bartlett Learning|location=Sudbury|isbn=978-1-284-05399-9|page=40|edition=15th|url=https://books.google.com/books?id=BwqEAgAAQBAJ&pg=PA40|url-status=live|archive-url=https://web.archive.org/web/20160131114409/https://books.google.com/books?id=BwqEAgAAQBAJ&pg=PA40|archive-date=January 31, 2016|df=mdy-all}}</ref><ref>{{cite web |title=NADAC as of 2019-09-25 {{!}} Data.Medicaid.gov |url=https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-09-25/s3gx-n3zd |website=Centers for Medicare and Medicaid Services |accessdate=26 September 2019 |language=en}}</ref> In other animals it is used to prevent and treat [[heartworm]] among other diseases.<ref name=Sau2015>{{cite book|title=Saunders Handbook of Veterinary Drugs: Small and Large Animal|date=2015|publisher=Elsevier Health Sciences|isbn=978-0-323-24486-2|page=420|edition=4|url=https://books.google.com/books?id=SJvmCgAAQBAJ&pg=PA420|url-status=live|archive-url=https://web.archive.org/web/20160131142826/https://books.google.com/books?id=SJvmCgAAQBAJ&pg=PA420|archive-date=January 31, 2016|df=mdy-all}}</ref>\n\n== Medical uses ==\n===Pinworms===\nIvermectin is as effective as albendazole or alternative antinematode drugs for treatment of [[pinworm infection]] (enterobiasis).<ref>{{cite journal | vauthors = Ottesen EA, Campbell WC | title = Ivermectin in human medicine | journal = The Journal of Antimicrobial Chemotherapy | volume = 34 | issue = 2 | pages = 195\u2013203 | date = August 1994 | pmid = 7814280 | doi =  10.1093/jac/34.2.195}}</ref>\n\n===River blindness===\nIvermectin is used for prevention, treatment, and control of [[onchocerciasis|river blindness]] (onchocerciasis) in populations where the disease is common. However, ivermectin is contraindicated in persons with a high burden of [[loiasis]] (e.g., >20,000 Loa loa microfilariae per mL), due to risk of ivermectin-associated severe inflammatory events.<ref>{{cite journal | vauthors = Keating J, Yukich JO, Mollenkopf S, Tediosi F | title = Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: a systematic review | journal = Acta Tropica | volume = 135 | issue =  | pages = 86\u201395 | date = July 2014 | pmid = 24699086 | doi = 10.1016/j.actatropica.2014.03.017 }}</ref>\n\nA single dose of ivermectin reduces microfilaridermia by 98\u201399% after 1\u20132 months.<ref>{{cite journal | vauthors = Bas\u00e1\u00f1ez MG, Pion SD, Boakes E, Filipe JA, Churcher TS, Boussinesq M |url= https://www.academia.edu/10555590 | title = Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis | journal = The Lancet. Infectious Diseases | volume = 8 | issue = 5 | pages = 310\u201322 | date = May 2008 | pmid = 18471776 | doi = 10.1016/S1473-3099(08)70099-9 }}</ref> Ivermectin does not kill adult worms. A single oral dose of ivermectin, taken once or twice a year for the 10{{ndash}}15-year lifespan of the adult worms, is required to protect the individual from river blindness.<ref name=\"UFAR Treatment\">{{cite web|author=United Front Against Riverblindness |title=Control of Riverblindness |url=http://www.riverblindness.org/index.php?menu=tn3&page=Treatment |archive-url=https://web.archive.org/web/20070827154413/http://www.riverblindness.org/index.php?menu=tn3&page=Treatment |archive-date=August 27, 2007 |url-status=dead }}</ref>\n\nA 2012 [[Cochrane (organisation)|Cochrane review]] found weak evidence suggesting that ivermectin could result in the reduction of chorioretinal lesions and prevent loss of vision in people with river blindness.<ref name=\"Ejere\">{{cite journal | vauthors = Ejere HO, Schwartz E, Wormald R, Evans JR | title = Ivermectin for onchocercal eye disease (river blindness) | journal = The Cochrane Database of Systematic Reviews | volume = 8 | issue = 8 | pages = CD002219 | date = August 2012 | pmid = 22895928 | pmc = 4425412 | doi = 10.1002/14651858.CD002219.pub2 }}</ref> [[Moxidectin]] has been approved by the FDA for use in people with river blindness, has a longer half-life than ivermectin, and may eventually supplant ivermectin, as it is a more potent microfilaricide, but there is a need for additional clinical trials, with long-term follow-up, to assess whether moxidectin is safe and effective for treatment of nematode infection in children and women of childbearing potential.<ref>{{cite journal | vauthors = Maheu-Giroux M, Joseph SA | title = Moxidectin for deworming: from trials to implementation | journal = The Lancet. Infectious Diseases | volume = 18 | issue = 8 | pages = 817\u2013819 | date = August 2018 | pmid = 29858152 | doi = 10.1016/S1473-3099(18)30270-6 }}</ref><ref>{{cite journal | vauthors = Boussinesq M | title = A new powerful drug to combat river blindness | journal = Lancet | volume = 392 | issue = 10154 | pages = 1170\u20131172 | date = October 2018 | pmid = 29361336 | doi = 10.1016/S0140-6736(18)30101-6 }} {{open access}}</ref>\n\n===Loa loa filariasis===\nA single dose of ivermectin gives a rapid and durable decrease in body burden of [[Loa loa|eyeworm]] (''Loa loa''). The risk of ivermectin-associated severe adverse drug events is very low in persons with less than 20,000 microfilariae per mL of blood.<ref>{{cite journal | vauthors = Pion SD, Tchatchueng-Mbougua JB, Chesnais CB, Kamgno J, Gardon J, Chippaux JP, Ranque S, Ernould JC, Garcia A, Boussinesq M | display-authors = 6 | title = Loa loa Microfilaremia: Systematic Review and Meta-analysis | journal = Open Forum Infectious Diseases | volume = 6 | issue = 4 | pages = ofz019 | date = April 2019 | pmid = 30968052 | pmc = 6449757 | doi = 10.1093/ofid/ofz019 }}</ref>\n\n===Threadworm===\nIvermectin is more effective than albendazole and equally as effective as thiabendazole for treatment of [[Pinworm (parasite)|threadworm]] (enterobiasis). Ivermectin has fewer adverse effects than does thiabendazole and is at least as well tolerated as albendazole.<ref>{{cite journal | vauthors = Henriquez-Camacho C, Gotuzzo E, Echevarria J, White AC, Terashima A, Samalvides F, P\u00e9rez-Molina JA, Plana MN | title = Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection | journal = The Cochrane Database of Systematic Reviews | volume =  | issue = 1 | pages = CD007745 | date = January 2016 | pmid = 26778150 | pmc = 4916931 | doi = 10.1002/14651858.CD007745.pub3 }}</ref> An analysis based on an economic model suggests that it is cost effective for people moving to Europe from areas where threadworm is common to be given a single-dose of ivermectin on arrival so as to cure presumptive infection with threadworm.<ref>{{cite journal |vauthors=Agbata EN, Morton RL, Bisoffi Z, Bottieau E, Greenaway C, Biggs BA, Montero N, Tran A, Rowbotham N, Arevalo-Rodriguez I, Myran DT, Noori T, Alonso-Coello P, Pottie K, Requena-M\u00e9ndez A |title=Effectiveness of Screening and Treatment Approaches for Schistosomiasis and Strongyloidiasis in Newly-Arrived Migrants from Endemic Countries in the EU/EEA: A Systematic Review |journal=Int J Environ Res Public Health |volume=16 |issue=1 |pages= 11|date=December 2018 |pmid=30577567 |doi=10.3390/ijerph16010011 |url=|pmc=6339107 }}</ref> Persons who are immunocompromised or who will receive immunosuppressive treatment and who have confirmed or presumptive threadworm infestation are likely to benefit from treatment with ivermectin.<ref>{{cite book | last1=Kotton | first1=Camille | last2=Mileno | first2=Maria | first3 = J. |last3 = Keystone | name-list-format = vanc | title = Travel medicine | chapter = The Immunocompromised Traveler| pages = 269\u2013277 | publisher = Elsevier | location = Edinburgh | year = 2019 | isbn = 978-0-323-54696-6 }}</ref>\n\n===Whipworm===\nCombination therapy with ivermectin plus albendazole is effective for treatment of [[Trichuris trichiura|whipworm]] (''Trichuris trichiura'') and the rate of [[Mazzotti reaction]] is no higher than for albendazole alone.<ref>{{cite journal | vauthors = Palmeirim MS, H\u00fcrlimann E, Knopp S, Speich B, Belizario V, Joseph SA, Vaillant M, Olliaro P, Keiser J | title = Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: A systematic review, meta-analysis and individual patient data analysis | journal = PLoS Neglected Tropical Diseases | volume = 12 | issue = 4 | pages = e0006458 | date = April 2018 | pmid = 29702653 | pmc = 5942849 | doi = 10.1371/journal.pntd.0006458 }}</ref>\n\n===Lymphatic filariasis===\nCombination therapy with ivermectin plus albendazole is effective for treatment of [[Lymphatic filariasis]] due to ''[[Wuchereria bancrofti]]'',<ref>{{cite journal | vauthors = de Kraker ME, Stolk WA, van Oortmarssen GJ, Habbema JD | title = Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti | journal = Tropical Medicine & International Health | volume = 11 | issue = 5 | pages = 718\u201328 | date = May 2006 | pmid = 16640625 | doi = 10.1111/j.1365-3156.2006.01606.x }} {{free access}}</ref> ''[[Brugia malayi]]'', or ''[[Brugia timori]]''.<ref>{{cite journal | vauthors = Taylor MJ, Hoerauf A, Bockarie M | title = Lymphatic filariasis and onchocerciasis | journal = Lancet | volume = 376 | issue = 9747 | pages = 1175\u201385 | date = October 2010 | pmid = 20739055 | doi = 10.1016/S0140-6736(10)60586-7 }}</ref>\n\n=== Arthropod ===\n\nEvidence supports its use against parasitic arthropods and insects:\n* [[Mites]] such as [[scabies]]:<ref name=\"pmid12174005\">{{cite journal | vauthors = Brooks PA, Grace RF | title = Ivermectin is better than benzyl benzoate for childhood scabies in developing countries | journal = Journal of Paediatrics and Child Health | volume = 38 | issue = 4 | pages = 401\u20134 | date = August 2002 | pmid = 12174005 | doi = 10.1046/j.1440-1754.2002.00015.x | url = https://pdfs.semanticscholar.org/a1cd/123fb05e94a926deb6daf430768e230bf88c.pdf }}</ref><ref name=\"pmid11207977\">{{cite journal | vauthors = Victoria J, Trujillo R |url= https://www.academia.edu/28824816 | title = Topical ivermectin: a new successful treatment for scabies | journal = Pediatric Dermatology | volume = 18 | issue = 1 | pages = 63\u20135 | year = 2001 | pmid = 11207977 | doi = 10.1046/j.1525-1470.2001.018001063.x }}</ref><ref name=\"pmid17636630\">{{cite journal | vauthors = Strong M, Johnstone P | title = Interventions for treating scabies | journal = The Cochrane Database of Systematic Reviews | volume =  | issue = 3 | pages = CD000320 | date = July 2007 | pmid = 17636630 | pmc = 6532717 | doi = 10.1002/14651858.CD000320.pub2 | veditors = Strong M }}</ref> It is usually limited to cases that prove to be resistant to topical treatments or that present in an advanced state (such as [[Norwegian scabies]]).<ref name=\"pmid17636630\" /> One review found that the efficacy of permethrin is similar to that of systemic or topical ivermectin.<ref>{{cite journal |vauthors=Rosumeck S, Nast A, Dressler C |title=Ivermectin and permethrin for treating scabies |journal=Cochrane Database Syst Rev |volume=4 |issue= |pages=CD012994 |date=April 2018 |pmid=29608022 |pmc=6494415 |doi=10.1002/14651858.CD012994 |url=}}</ref> A separate review found that although oral ivermectin is usually effective for treatment of scabies, it does have a higher treatment failure rate than topical permethrin.<ref>{{cite journal | vauthors = Dhana A, Yen H, Okhovat JP, Cho E, Keum N, Khumalo NP | title = Ivermectin versus permethrin in the treatment of scabies: A systematic review and meta-analysis of randomized controlled trials | journal = Journal of the American Academy of Dermatology | volume = 78 | issue = 1 | pages = 194\u2013198 | date = January 2018 | pmid = 29241784 | doi = 10.1016/j.jaad.2017.09.006 }}</ref> Another review found that oral ivermectin provided a reasonable balance between efficacy and safety.<ref name=\"Thadanipon2019\">{{cite journal|vauthors=Thadanipon K, Anothaisintawee T, Rattanasiri S, Thakkinstian A, Attia J | title=Efficacy and safety of antiscabietic agents: A systematic review and network meta-analysis of randomized controlled trials. | journal=J Am Acad Dermatol | year= 2019 | volume=  80| issue=  5| pages=  1435\u20131444| pmid=30654070 | doi=10.1016/j.jaad.2019.01.004 | pmc= }} {{open access}} </ref> Since ivermectin is more convenient than permethrin,<ref>{{cite journal | vauthors = Crump A, \u014cmura S | title = Ivermectin, 'wonder drug' from Japan: the human use perspective | journal = Proceedings of the Japan Academy. Series B, Physical and Biological Sciences | volume = 87 | issue = 2 | pages = 13\u201328 | date = 10 February 2011 | pmid = 21321478 | pmc = 3043740 | doi = 10.2183/pjab.87.13 | bibcode = 2011PJAB...87...13C }}</ref> many have turned to veterinary sources of the drug to obtain assurance of a cure at an affordable price.<ref>{{cite journal | vauthors = Laing R, Gillan V, Devaney E | title = Ivermectin - Old Drug, New Tricks? | journal = Trends in Parasitology | volume = 33 | issue = 6 | pages = 463\u2013472 | date = June 2017 | pmid = 28285851 | pmc = 5446326 | doi = 10.1016/j.pt.2017.02.004 }} {{open access}}</ref>\n* [[louse|Lice]]:<ref name=\"Dourmishev AL 2004\">{{cite journal | vauthors = Dourmishev AL, Dourmishev LA, Schwartz RA |url= https://www.academia.edu/33924249 | title = Ivermectin: pharmacology and application in dermatology | journal = International Journal of Dermatology | volume = 44 | issue = 12 | pages = 981\u20138 | date = December 2005 | pmid = 16409259 | doi = 10.1111/j.1365-4632.2004.02253.x }}</ref><ref>{{cite journal | vauthors = Strycharz JP, Yoon KS, Clark JM | title = A new ivermectin formulation topically kills permethrin-resistant human head lice (Anoplura: Pediculidae) | journal = Journal of Medical Entomology | volume = 45 | issue = 1 | pages = 75\u201381 | date = January 2008 | pmid = 18283945 | doi = 10.1603/0022-2585(2008)45[75:ANIFTK]2.0.CO;2 }}</ref> Ivermectin lotion (0.5%) is FDA-approved for patients six months of age and older.<ref>{{cite web | url = https://www.drugs.com/sklice.html | title = Sklice lotion | archive-url =   https://web.archive.org/web/20120512075611/http://www.drugs.com/sklice.html | archive-date = 12 May 2012 | work = drugs.com }}</ref> After a single, 10-minute application of this formulation on dry hair, 78% of subjects were found to be free of lice after two weeks.<ref name=nejm>{{cite journal | vauthors = Pariser DM, Meinking TL, Bell M, Ryan WG | title = Topical 0.5% ivermectin lotion for treatment of head lice | journal = The New England Journal of Medicine | volume = 367 | issue = 18 | pages = 1687\u201393 | date = 1 November 2012 | pmid = 23113480 | doi = 10.1056/NEJMoa1200107 }} {{free access}}</ref> This level of effectiveness is equivalent to other [[pediculicide]] treatments requiring two applications.<ref>{{cite web | first = Melissa | last = Healy | name-list-format = vanc |publisher=Los Angeles Times |date= 1 November 2012 |title=New treatment for lice is highly effective, study reports  | url = https://web.archive.org/web/20200101192821/https://www.latimes.com/health/la-xpm-2012-nov-01-la-heb-lice-treatment-20121101-story.html }}</ref>\n* [[Cimex|Bedbug]]s: There is tentative evidence that ivermectin kills [[bedbug]]s, as part of [[integrated pest management]] for [[bedbug infestation]]s.<ref>{{cite journal |vauthors=Crump A |title=Ivermectin: enigmatic multifaceted 'wonder' drug continues to surprise and exceed expectations |journal=J. Antibiot. |volume=70 |issue=5 |pages=495\u2013505 |date=May 2017 |pmid=28196978 |doi=10.1038/ja.2017.11 }} {{free access}}</ref><ref>{{cite journal |vauthors=\u014cmura S |title=A Splendid Gift from the Earth: The Origins and Impact of the Avermectins (Nobel Lecture) |journal=Angew. Chem. Int. Ed. Engl. |volume=55 |issue=35 |pages=10190\u2013209 |date=August 2016 |pmid=27435664 |doi=10.1002/anie.201602164 |url=https://www.nobelprize.org/prizes/medicine/2015/omura/lecture/ }}</ref><ref>{{cite book |last1=James |first1=William D. |last2=Elston |first2=Dirk |last3=Berger |first3=Timothy |last4=Neuhaus |first4=Isaac | name-list-format = vanc |title=Andrews' Diseases of the Skin: Clinical Dermatology |date=2015 |publisher=Elsevier Health Sciences |isbn=9780323319690 |page=439 |url=https://books.google.com/books?id=Np6cCQAAQBAJ&pg=PA439 |language=en |quote=Ivermectin treatment is emerging as a potential ancillary measure.}}</ref> Such use however may required a prolonged course of treatment which is of unclear safety.<ref>{{cite book |last1=Lebwohl |first1=Mark G. |last2=Heymann |first2=Warren R. |last3=Berth-Jones |first3=John |last4=Coulson |first4=Ian | name-list-format = vanc |title=Treatment of Skin Disease: Comprehensive Therapeutic Strategies |date=2017 |publisher=Elsevier Health Sciences |isbn=9780702069130 |page=89 |url=https://books.google.com/books?id=KuM2DwAAQBAJ&pg=PA89 |language=en}}</ref>\n* [[Malaria]]-bearing [[mosquito]]s, such as [[Anopheles gambiae]]: Mass drug administration of a population with ivermectin for purposes of treating/preventing nematode infestation is effective for eliminating malaria-bearing mosquitos and thereby reducing infection with residual [[Plasmodium falciparum|malaria parasites]].<ref>{{cite journal |vauthors=Tizifa TA, Kabaghe AN, McCann RS, van den Berg H, Van Vugt M, Phiri KS |title=Prevention Efforts for Malaria |journal=Curr Trop Med Rep |volume=5 |issue=1 |pages=41\u201350 |date=2018 |pmid=29629252 |pmc=5879044 |doi=10.1007/s40475-018-0133-y |url=}}</ref>\n\n=== Rosacea ===\nA review found that ivermectin was effective for treatment of [[rosacea]].<ref>{{cite journal |vauthors=Siddiqui K, Stein Gold L, Gill J |title=The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis |journal=SpringerPlus |volume=5 |issue=1 |pages=1151 |date=2016 |pmid=27504249 |pmc=4956638 |doi=10.1186/s40064-016-2819-8 |url=}}</ref> An ivermectin cream has been approved by the [[FDA]], as well as in Europe, for the treatment of inflammatory [[lesion]]s of [[rosacea]]. The treatment is based upon the hypothesis that parasitic mites of the genus ''[[Demodex]]'' play a role in rosacea.<ref>{{cite journal |vauthors=Moran EM, Foley R, Powell FC |title=Demodex and rosacea revisited |journal=Clin. Dermatol. |volume=35 |issue=2 |pages=195\u2013200 |date=2017 |pmid=28274359 |doi=10.1016/j.clindermatol.2016.10.014 |url=}}</ref> In a clinical study, ivermectin reduced lesions by 83% over 4 months, as compared to 74% under a [[metronidazole]] standard therapy.<ref>{{cite web | url = https://www.drugs.com/newdrugs/galderma-receives-fda-approval-soolantra-ivermectin-cream-rosacea-4135.html | title = Galderma Receives FDA Approval of Soolantra (Ivermectin) Cream for Rosacea | archive-url = https://web.archive.org/web/20150122021246/http://www.drugs.com/newdrugs/galderma-receives-fda-approval-soolantra-ivermectin-cream-rosacea-4135.html | archive-date=January 22, 2015 | work = drugs.com }}\"</ref>\n\n== Contraindications ==\nIvermectin is contraindicated in children under the age of five or those who weigh less than {{convert|15|kg|abbr=off}},<ref name=\"Dourmishev AL 2004\"/> women who are breastfeeding, and individuals with liver or kidney disease.<ref>{{cite journal | vauthors = Heukelbach J, Winter B, Wilcke T, Muehlen M, Albrecht S, de Oliveira FA, Kerr-Pontes LR, Liesenfeld O, Feldmeier H | title = Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population | journal = Bulletin of the World Health Organization | volume = 82 | issue = 8 | pages = 563\u201371 | date = August 2004 | pmid = 15375445 | pmc = 2622929 | url = https://scielosp.org/pdf/bwho/2004.v82n8/563-571/en }}</ref>\n\n== Adverse effects ==\n\nThe main concern is neurotoxicity, which in most mammalian species may manifest as [[central nervous system depression]], and consequent [[ataxia]], as might be expected from potentiation of inhibitory GABA-ergic synapses.\n\nDogs with defects in the [[P-glycoprotein]] gene (''MDR1''), often collie-like herding dogs, can be severely poisoned by ivermectin. The mnemonic \"white feet, don't treat\" refers to Scotch collies that are vulnerable to ivermectin.<ref>{{cite journal |vauthors=Dowling P |title=Pharmacogenetics: it's not just about ivermectin in collies |journal=Can. Vet. J. |volume=47 |issue=12 |pages=1165\u20138 |date=December 2006 |pmid=17217086 |pmc=1636591 |doi= |url=}}</ref>\n\nSince drugs that inhibit the enzyme [[CYP3A4]] often also inhibit P-glycoprotein transport, the risk of increased absorption past the blood-brain barrier exists when ivermectin is administered along with other CYP3A4 inhibitors. These drugs include statins, HIV protease inhibitors, many calcium channel blockers, lidocaine, the benzodiazepines, and glucocorticoids such as dexamethasone.<ref>[https://dvmbooks.weebly.com/uploads/2/2/3/6/22365786/2._goodman_and_gilman.pdf#page=148&zoom=auto,-29,535 Goodman and Gilman's The Pharmacological Basis of Therapeutics], 11th edition, pages 122, 1084\u20131087.</ref>\n\nFor dogs, the insecticide [[spinosad]] may have the effect of increasing the potency of ivermectin.<ref>{{cite web|title=COMFORTIS\u00ae and ivermectin interaction Safety Warning Notification|url=https://www.fda.gov/animalveterinary/newsevents/cvmupdates/ucm047942.htm|publisher=U.S. Food and Drug Administration (FDA) Center for Veterinary Medicine (CVM)|archive-url=https://web.archive.org/web/20090829064135/https://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm047942.htm|archive-date=August 29, 2009}}</ref>\n\n== Pharmacology ==\n\n=== Pharmacodynamics ===\n\nIvermectin and other avermectins ([[insecticide]]s most frequently used in home-use [[ant]] baits) are [[cyclic compound|macrocyclic]] [[lactones]] derived from the [[bacterium]] ''[[Streptomyces avermitilis]]''. Ivermectin kills by interfering with [[nervous system]] and [[muscle]] function, in particular by enhancing inhibitory [[neurotransmission]].\n\nThe drug binds to glutamate-gated [[chloride channels]] (GluCls) in the membranes of [[invertebrate]] nerve and muscle cells, causing increased permeability to chloride ions, resulting in cellular hyper-polarization, followed by paralysis and death.<ref name=AHFS2016 /><ref name=\"pmid15313134\">{{cite journal | vauthors = Yates DM, Wolstenholme AJ | title = An ivermectin-sensitive glutamate-gated chloride channel subunit from Dirofilaria immitis | journal = International Journal for Parasitology | volume = 34 | issue = 9 | pages = 1075\u201381 | date = August 2004 | pmid = 15313134 | doi = 10.1016/j.ijpara.2004.04.010 }}</ref> GluCls are invertebrate-specific members of the [[Cys-loop]] family of [[ligand-gated ion channel]]s present in [[neuron]]s and [[myocyte]]s.\n\n=== Pharmacokinetics ===\n\nIvermectin can be given by mouth, topically, or via injection. It does not readily cross the [[blood\u2013brain barrier]] of [[mammal]]s due to the presence of [[P-glycoprotein]],<ref>{{cite journal | vauthors = Borst P, Schinkel AH | title = What have we learnt thus far from mice with disrupted P-glycoprotein genes? | journal = European Journal of Cancer | volume = 32A | issue = 6 | pages = 985\u201390 | date = June 1996 | pmid = 8763339 | doi = 10.1016/0959-8049(96)00063-9 }}</ref> (the ''MDR1'' gene mutation affects function of this protein). Crossing may still become significant if ivermectin is given at high doses (in which case, brain levels peak 2\u20135 hours after administration).\nIn contrast to mammals, ivermectin can cross the blood\u2013brain barrier in tortoises, often with fatal consequences.\n\n=== Ecotoxicity ===\n\nField studies have demonstrated the dung of animals treated with ivermectin supports a significantly reduced diversity of invertebrates, and the dung persists longer.<ref>{{cite journal | vauthors = Iglesias LE, Saumell CA, Fern\u00e1ndez AS, Fus\u00e9 LA, Lifschitz AL, Rodr\u00edguez EM, Steffan PE, Fiel CA |url= https://www.researchgate.net/publication/6964038 | title = Environmental impact of ivermectin excreted by cattle treated in autumn on dung fauna and degradation of faeces on pasture | journal = Parasitology Research | volume = 100 | issue = 1 | pages = 93\u2013102 | date = December 2006 | pmid = 16821034 | doi = 10.1007/s00436-006-0240-x }}</ref>\n\n== History ==\n\nThe discovery of the [[avermectin]] family of compounds, from which ivermectin is chemically derived, was made by [[Satoshi \u014cmura]] of Kitasato University, Tokyo and [[William C. Campbell (scientist)|William C. Campbell]] of the Merck Institute for Therapeutic research. \u014cmura identified avermectin from the bacterium ''[[Streptomyces avermitilis]]''. Campbell purified avermectin from cultures obtained from \u014cmura and led efforts leading to the discovery of ivermectin, a derivative of greater potency and lower toxicity.<ref>{{cite journal | vauthors = Fisher MH, Mrozik H | title = The chemistry and pharmacology of avermectins | journal = Annual Review of Pharmacology and Toxicology | volume = 32 | issue =  | pages = 537\u201353 | year = 1992 | pmid = 1605577 | doi = 10.1146/annurev.pa.32.040192.002541 }} {{free access}}</ref> Ivermectin was introduced in 1981.<ref>{{cite book | vauthors = Campbell WC, Burg RW, Fisher MH, Dybas RA | chapter = Chapter 1: The discovery of ivermectin and other avermectins |title=Pesticide Synthesis Through Rational Approaches|volume=255 | pages = 5\u201320 |date=June 26, 1984 |publisher=American Chemical Society|doi=10.1021/bk-1984-0255.ch001|isbn=978-0-8412-1083-7|series=ACS Symposium Series}} {{free access}}</ref> Half of the 2015 [[Nobel Prize in Physiology or Medicine]] was awarded jointly to Campbell and \u014cmura for discovering avermectin, \"the  derivatives  of which have radically lowered the incidence of [[Onchocerciasis|river blindness]] and [[lymphatic filariasis]], as well as showing efficacy against an expanding number of other  parasitic diseases\".<ref name=\"nobel-2015\">{{cite web|url=https://www.nobelprize.org/nobel_prizes/medicine/laureates/2015/press.pdf|title=The Nobel Prize in Physiology or Medicine 2015|publisher=Nobel Foundation|access-date=October 7, 2015|url-status=live|archive-url=https://web.archive.org/web/20151006112430/http://www.nobelprize.org/nobel_prizes/medicine/laureates/2015/press.pdf|archive-date=October 6, 2015|df=mdy-all}}</ref>\n\n==Society and culture==\n===Cost===\nThe wholesale cost in the [[developing world]] is about US$0.12 for a course of treatment as of 2014.<ref name=MSH2014/> This is down from an initial cost of US$6 proposed by Merck in 1987.<ref name=Crump2011>{{cite journal | vauthors = Crump A, \u014cmura S | title = Ivermectin, 'wonder drug' from Japan: the human use perspective | journal = Proceedings of the Japan Academy. Series B, Physical and Biological Sciences | volume = 87 | issue = 2 | pages = 13\u201328 | date = 2011 | pmid = 21321478 | pmc = 3043740 | doi = 10.2183/pjab.87.13 | bibcode = 2011PJAB...87...13C }}</ref> The company however has donated 100s of millions of courses of treatments since 1988 in more than 30 countries.<ref name=Crump2011/> Between 1995 and 2010 the program using donated ivermectin to prevent river blindness is estimated to have prevented 7 million years of disability well costing US$257 million.<ref>{{cite book |last1=Omaswa |first1=Francis |last2=Crisp |first2=Nigel | name-list-format = vanc |title=African Health Leaders: Making Change and Claiming the Future |date=2014 |publisher=OUP Oxford |isbn=9780191008412 |page=PT158 |url=https://books.google.com/books?id=e0nYBAAAQBAJ&pg=PT158 |language=en}}</ref>\n\nIn the United States a course of treatment with pills costs about US$25\u201350 for a typical adult.<ref name=Ric2014/> As of 2019 ivermectin tablets were the least expensive treatment option for lice in children at about US$10.<ref name=Nelson2019>{{cite book |last1=Kliegman |first1=Robert M. |last2= St Geme |first2=Joseph | name-list-format = vanc |title=Nelson Textbook of Pediatrics E-Book |date=2019 |publisher=Elsevier Health Sciences |isbn=9780323568883 |page=3575 |url=https://books.google.com/books?id=LJuRDwAAQBAJ&pg=PA3867 |language=en}}</ref> The hair lotion, however, is about US$300 for a course of treatment.<ref name=Nelson2019/>\n\n=== Brand names ===\nIvermectin is available as a generic prescription drug in the U.S. in a 3&nbsp;mg tablet formulation.<ref>{{cite web |last1=U.S. FDA |title=Abbreviated New Drug Application (ANDA): 204154 |url=https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204154 |website=Drugs@FDA: FDA Approved Drug Products |publisher=U.S. Food and Drug Administration |access-date=18 August 2018}}</ref> It is also sold under the brand names Heartgard, Sklice<ref>{{cite web|url=http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c5557cd-c4cf-11df-851a-0800200c9a66|title=SKLICE- ivermectin lotion (NDC Code(s): 49281-183-71)|website=DailyMed|date=February 2012|access-date=September 9, 2015|url-status=live|archive-url=https://web.archive.org/web/20160306023406/http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c5557cd-c4cf-11df-851a-0800200c9a66|archive-date=March 6, 2016|df=mdy-all}}</ref> and Stromectol<ref>{{cite web|url=http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=681888c9-af79-4b7d-ae80-c3f4f6f1effd|title=STROMECTOL- ivermectin tablet (NDC Code(s): 0006-0032-20)|website=DailyMed|date=May 2010|access-date=September 9, 2015|url-status=live|archive-url=https://web.archive.org/web/20160306025605/http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=681888c9-af79-4b7d-ae80-c3f4f6f1effd|archive-date=March 6, 2016|df=mdy-all}}</ref> in the United States, Ivomec worldwide by Merial Animal Health, Mectizan in Canada by [[Merck & Co.|Merck]], Iver-DT<ref>{{cite web|title = ALIVE PHARMACEUTICAL (P) LTD.: Iver-DT|url = http://alivepharmaceutical.blogspot.com/2014/05/iver-dt.html|website = ALIVE PHARMACEUTICAL (P) LTD.|date = May 27, 2014|access-date = October 7, 2015|first = Santosh|last = Adhikari | name-list-format = vanc |url-status = live |archive-url = https://web.archive.org/web/20160304223410/http://alivepharmaceutical.blogspot.com/2014/05/iver-dt.html |archive-date = March 4, 2016 |df = mdy-all}}</ref> in Nepal by Alive Pharmaceutical and Ivexterm in Mexico by [[Valeant Pharmaceuticals International]]. In Southeast Asian countries, it is marketed by Delta Pharma Ltd. under the trade name Scabo 6. The formulation for rosacea treatment is sold as Soolantra. While in development, it was assigned the code MK-933 by Merck.<ref>{{cite journal | vauthors = Pampiglione S, Majori G, Petrangeli G, Romi R | title = Avermectins, MK-933 and MK-936, for mosquito control | journal = Transactions of the Royal Society of Tropical Medicine and Hygiene | volume = 79 | issue = 6 | pages = 797\u20139 | year = 1985 | pmid = 3832491 | doi = 10.1016/0035-9203(85)90121-X }}</ref>\n\n== Veterinary use ==\n\nIvermectin is routinely used to control parasitic worms in the gastrointestinal tract of [[ruminant animals]]. These parasites normally enter the animal when it is grazing, pass the bowel and set and mature in the intestines, after which they produce eggs which leave the animal via its droppings and can infest new pastures. Ivermectin is effective in killing some, but not all, of these parasites.{{fact|date=September 2019}}\n\nIn dogs it is used to routinely used prevent [[Dirofilaria immitis|heartworm.]]<ref>{{Citation|last=Papich|first=Mark G.|title=Ivermectin|date=2016-01-01|url=http://www.sciencedirect.com/science/article/pii/B9780323244855003235|work=Saunders Handbook of Veterinary Drugs (Fourth Edition)|pages=420\u2013423|editor-last=Papich|editor-first=Mark G.|publisher=W.B. Saunders|language=en|isbn=978-0-323-24485-5|access-date=2020-04-07}}</ref> Some dog breeds (especially the [[Rough Collie]], the [[Smooth Collie]], the [[Shetland Sheepdog]], and the [[Australian Shepherd]]), though, have a high incidence of a certain mutation within the ''[[MDR1]]'' gene (coding for [[P-glycoprotein]]); affected animals are particularly sensitive to the toxic effects of ivermectin.<ref>{{cite web | url = http://www.ashgi.org/articles/mdr1.htm | title = MDR1 FAQs | archive-url = https://web.archive.org/web/20071213125320/http://www.ashgi.org/articles/mdr1.htm | archive-date=December 13, 2007 | publisher = Australian Shepherd Health & Genetics Institute, Inc. }}</ref><ref>{{cite web | url = http://vcpl.vetmed.wsu.edu/vcpl-home | title = Multidrug Sensitivity in Dogs | archive-url = https://web.archive.org/web/20150623212433/http://vcpl.vetmed.wsu.edu/vcpl-home | archive-date = June 23, 2015 | publisher = Washington State University's College of Veterinary Medicine }}</ref> Clinical evidence suggests kittens are susceptible to ivermectin toxicity.<ref>{{cite journal | vauthors = Frischke H, Hunt L | title = Alberta. Suspected ivermectin toxicity in kittens | journal = The Canadian Veterinary Journal | volume = 32 | issue = 4 | pages = 245 | date = April 1991 | pmid = 17423775 | pmc = 1481314 | doi =  }}</ref> A 0.01% ivermectin topical preparation for treating [[ear mite]]s in cats is available.<ref>{{cite web | url=https://www.bi-vetmedica.com/species/pet/products/acarexx.html |title = Acarexx |date = April 11, 2016 | publisher = Boehringer Ingelheim }}</ref>\n\nIvermectin is sometimes used as an [[acaricide]] in reptiles, both by injection and as a diluted spray. While this works well in some cases, care must be taken, as several species of reptiles are very sensitive to ivermectin. Use in turtles is particularly contraindicated.<ref>{{cite book | last = Klingenberg | first = Roger | name-list-format = vanc | title = Understanding reptile parasites: from the experts at Advanced Vivarium Systems | publisher = Advanced Vivarium Systems | location = Irvine, Calif | year = 2007 | isbn = 978-1882770908 }}</ref>\n\n== Research ==\n\nIvermectin is also being studied as a potential antiviral agent against the [[chikungunya]] and [[yellow fever]].<ref>{{cite journal | vauthors = Varghese FS, Kaukinen P, Gl\u00e4sker S, Bespalov M, Hanski L, Wennerberg K, K\u00fcmmerer BM, Ahola T | title = Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses | journal = Antiviral Research | volume = 126 | issue =  | pages = 117\u201324 | date = February 2016 | pmid = 26752081 | doi = 10.1016/j.antiviral.2015.12.012 }}</ref>\n\nIn 2013, this antiparasitic drug was demonstrated as a novel ligand of [[farnesoid X receptor]] (FXR),<ref name=\"pmid25388537\">{{cite journal | vauthors = Carotti A, Marinozzi M, Custodi C, Cerra B, Pellicciari R, Gioiello A, Macchiarulo A |url= https://www.researchgate.net/publication/268231666 | title = Beyond bile acids: targeting Farnesoid X Receptor (FXR) with natural and synthetic ligands | journal = Current Topics in Medicinal Chemistry | volume = 14 | issue = 19 | pages = 2129\u201342 | year = 2014 | pmid = 25388537 | doi = 10.2174/1568026614666141112094058 }}</ref><ref>{{cite journal | vauthors = Jin L, Feng X, Rong H, Pan Z, Inaba Y, Qiu L, Zheng W, Lin S, Wang R, Wang Z, Wang S, Liu H, Li S, Xie W, Li Y | display-authors = 6 | title = The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism | journal = Nature Communications | volume = 4 | pages = 1937 | date = 2013 | pmid = 23728580 | doi = 10.1038/ncomms2924 | bibcode = 2013NatCo...4.1937J }} {{free access}}</ref> a therapeutic target for [[Nonalcoholic Fatty Liver Disease]].<ref>{{cite journal | vauthors = Kim SG, Kim BK, Kim K, Fang S | title = Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease | journal = Endocrinology and Metabolism | volume = 31 | issue = 4 | pages = 500\u2013504 | date = December 2016 | pmid = 28029021 | pmc = 5195824 | doi = 10.3803/EnM.2016.31.4.500 }}</ref>\n\nIvermectin is also of interest in the prevention of [[malaria]], as it is toxic to both the malaria plasmodium itself, and the mosquitos that carry it.<ref>{{cite journal | vauthors = Chaccour C, Hammann F, Rabinovich NR | title = Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety | journal = Malaria Journal | volume = 16 | issue = 1 | pages = 161 | date = April 2017 | pmid = 28434401 | pmc = 5402169 | doi = 10.1186/s12936-017-1801-4 }}</ref><ref>{{cite journal | vauthors = Siewe Fodjo JN, Kugler M, Hotterbeekx A, Hendy A, Van Geertruyden JP, Colebunders R | title = Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions? | journal = Infectious Diseases of Poverty | volume = 8 | issue = 1 | pages = 77 | date = August 2019 | pmid = 31439040 | pmc = 6706915 | doi = 10.1186/s40249-019-0588-7 }}</ref>\n\n===SARS-CoV-2===\nIvermectin inhibits replication of  [[SARS-CoV-2]] ''in vitro'' (in monkey kidney cell cultre) with an [[IC50|IC<sub>50</sub>]] of 2.2 - 2.8 \u00b5M, making it a possible candidate for [[COVID-19 drug repurposing research]].<ref>{{cite journal |last1=Caly |first1=Leon |last2=Druce |first2=Julian D. |last3=Catton |first3=Mike G. |last4=Jans |first4=David A. |last5=Wagstaff |first5=Kylie M. |title=The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro |journal=Antiviral Research |date=April 2020 |pages=104787 |doi=10.1016/j.antiviral.2020.104787}} {{open access}}</ref> Note that the doses used in cell culture would require 10{{sup|4}} larger doses in humans based on this data, which does not look promising as an effective treatment for Covid19.<ref>TWiV 599 | https://www.microbe.tv/twiv/twiv-599/</ref> Moreover, cell culture experiments also showed promise for treating Dengue virus infection, but later failed in animal models.<ref>TWiV 599 | https://www.microbe.tv/twiv/twiv-599/</ref>\n\nOn 10 April 2020, the FDA issued guidance to not use ivermectin intended for animals as treatment for COVID-19 in humans.<ref>{{cite web | title=Do Not Use Ivermectin for Animals as Treatment for COVID-19 in Humans | website=U.S. [[Food and Drug Administration]] (FDA) | date=10 April 2020 | url=https://www.fda.gov/animal-veterinary/product-safety-information/fda-letter-stakeholders-do-not-use-ivermectin-intended-animals-treatment-covid-19-humans | access-date=10 April 2020}}</ref>\n\n== See also ==\n* [[Carter Center]]\n* [[Neglected Diseases|Neglected diseases]]\n* [[United Front Against Riverblindness]]\n\n== References ==\n{{Reflist}}\n\n== External links ==\n* {{cite web | url = https://druginfo.nlm.nih.gov/drugportal/name/ivermectin | publisher = U.S. National Library of Medicine | work = Drug Information Portal | title = Ivermectin }}\n* [http://www.cartercenter.org/health/river_blindness/index.html The Carter Center River Blindness (Onchocerciasis) Control Program]\n* [https://www.youtube.com/watch?v=t96_xbpXH-M Trinity College Dublin. Prof William Campbell \u2013 The Story of Ivermectin]\n* {{cite web|url=https://reference.medscape.com/drug/stromectol-ivermectin-342657|title=ivermectin (Rx) Stromectol |website=Medscape }}\n* {{cite web | title=Ivermectin Topical | website=MedlinePlus | url=https://medlineplus.gov/druginfo/meds/a613011.html }}\n\n{{Anthelmintics}}\n{{Ectoparasiticides}}\n{{Navboxes\n| title = [[Pharmacodynamics]]\n| titlestyle = background:#ccccff\n| list1 = \n{{GABAA receptor positive modulators}}\n{{Glycine receptor modulators}}\n{{Nicotinic acetylcholine receptor modulators}}\n{{Purine receptor modulators}}\n}}\n{{Authority control}}\n{{portal bar|Pharmacy and pharmacology|Medicine}}\n\n[[Category:Acaricides]]\n[[Category:Antiparasitic agents]]\n[[Category:GABAA receptor positive allosteric modulators]]\n[[Category:Glycine receptor agonists]]\n[[Category:Insecticides]]\n[[Category:Japanese inventions]]\n[[Category:Macrolides]]\n[[Category:Merck & Co. brands]]\n[[Category:Nicotinic agonists]]\n[[Category:Peripherally selective drugs]]\n[[Category:Veterinary drugs]]\n[[Category:World Health Organization essential medicines]]\n[[Category:Chloride channel openers]]\n[[Category:RTT]]\n", "text_old": "{{Use mdy dates|date=May 2016}}\n{{Use American English|date=May 2016}}\n{{Drugbox\n| Verifiedfields = changed\n| Watchedfields = changed\n| verifiedrevid = 457127811\n| IUPAC_name = 22,23-dihydroavermectin B<sub>1a</sub> + 22,23-dihydroavermectin B<sub>1b</sub>\n| image = Ivermectin skeletal.svg\n| width = 300\n\n<!--Clinical data-->\n| tradename = Stromectol, Soolantra cream\n| Drugs.com = {{drugs.com|monograph|ivermectin}} ([[antiparasitic]])<br />{{Drugs.com|pro|soolantra-cream}} ([[rosacea]])\n| MedlinePlus = a607069\n| DailyMedID = Ivermectin\n| pregnancy_AU = B3\n| pregnancy_US = C\n| legal_US = Rx-only\n| routes_of_administration = By mouth, topical\n| ATC_prefix = D11\n| ATC_suffix = AX22\n| ATC_supplemental = {{ATC|P02|CF01}} {{ATCvet|P54|AA01}} {{ATCvet|S02|QA03}}\n\n<!--Pharmacokinetic data-->\n| bioavailability =\n| protein_bound = 93%\n| metabolism = Liver ([[CYP450]])\n| elimination_half-life = 18 hours\n| excretion = Feces; <1% urine\n\n<!--Identifiers-->\n| CAS_number_Ref = {{cascite|correct|??}}\n| CAS_number = 70288-86-7\n| CAS_supplemental = {{CAS|71827-03-7}}\n| PubChem = 9812710\n| DrugBank_Ref = {{drugbankcite|correct|drugbank}}\n| DrugBank = DB00602\n| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}\n| ChemSpiderID = 7988461\n| UNII_Ref = {{fdacite|correct|FDA}}\n| UNII = 8883YP2R6D\n| KEGG_Ref = {{keggcite|correct|kegg}}\n| KEGG = D00804\n| ChEMBL_Ref = {{ebicite|changed|EBI}}\n| ChEMBL = 341047\n| PDB_ligand = IVM\n\n<!--Chemical data-->\n| chemical_formula = {{Chem | C|48 | H|74 | O|14}} {{nowrap|1=(22,23-dihydroavermectin&nbsp;B<sub>1a</sub>)}}<br />{{Chem | C|47 | H|72 | O|14}} {{nowrap|1=(22,23-dihydroavermectin&nbsp;B<sub>1b</sub>)}}\n| molecular_weight = 875.10 g/mol\n| StdInChI_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChI = 1S/C48H74O14.C47H72O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38;1-24(2)41-27(5)16-17-46(61-41)22-33-19-32(60-46)15-14-26(4)42(25(3)12-11-13-31-23-54-44-39(48)28(6)18-34(45(50)57-33)47(31,44)51)58-38-21-36(53-10)43(30(8)56-38)59-37-20-35(52-9)40(49)29(7)55-37/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3;11-14,18,24-25,27,29-30,32-44,48-49,51H,15-17,19-23H2,1-10H3/b13-12+,27-15+,32-14+;12-11+,26-14+,31-13+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+;25-,27-,29-,30-,32+,33-,34-,35-,36-,37-,38-,39+,40-,41+,42-,43-,44+,46+,47+/m00/s1\n| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChIKey = SPBDXSGPUHCETR-JFUDTMANSA-N\n| smiles = CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C.C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)O[C@@H]1C(C)C\n}}\n<!-- Definition and medical uses -->\n'''Ivermectin''' is a medication used to treat many types of [[parasite]] infestations.<ref name=AHFS2016/> This includes [[head lice infestation|head lice]], [[scabies]], [[onchocerciasis|river blindness]] (onchocerciasis), [[strongyloidiasis]], [[trichuriasis]], [[ascariasis]], and [[lymphatic filariasis]].<ref name=AHFS2016/><ref>{{cite book |last1=Sneader |first1=Walter | name-list-format = vanc |title=Drug Discovery a History.|date=2005|publisher=John Wiley & Sons|location=Chichester|isbn=978-0-470-01552-0|page=333|url=https://books.google.com/books?id=jglFsz5EJR8C&pg=PA333}}</ref><ref name=Sau2015/><ref>{{cite web | author = CDC-Centers for Disease Control and Prevention |title= Ascariasis - Resources for Health Professionals |url= https://www.cdc.gov/parasites/ascariasis/health_professionals/index.html |website=www.cdc.gov |accessdate=28 December 2019 |language=en-us |date=23 August 2019}}</ref> It can be taken by mouth or applied to the skin for external infestations.<ref name=AHFS2016/><ref>{{cite journal | vauthors = Panahi Y, Poursaleh Z, Goldust M |url= https://www.annals-parasitology.eu/go.live.php/download_default/D660/2015-61-1_11.pdf | title = The efficacy of topical and oral ivermectin in the treatment of human scabies | journal = Annals of Parasitology | volume = 61 | issue = 1 | pages = 11\u201316 | date = 2015 | pmid = 25911032 }}</ref> Use in the eyes should be avoided.<ref name=AHFS2016 />\n\n<!-- Side effects and mechanism -->\nCommon side effects include [[Red eye (medicine)|red eyes]], dry skin, and burning skin.<ref name=AHFS2016>{{cite web|title=Ivermectin|url=https://www.drugs.com/monograph/ivermectin.html|publisher=The American Society of Health-System Pharmacists|access-date=16 January 2016|url-status=live|archive-url=https://web.archive.org/web/20160103191914/http://www.drugs.com/monograph/ivermectin.html|archive-date=January 3, 2016|df=mdy-all}}</ref> It is unclear if it is safe for use during [[pregnancy]], but is probably acceptable for use during [[breastfeeding]].<ref>{{cite web |title = Ivermectin Levels and Effects while Breastfeeding |url= https://www.drugs.com/breastfeeding/ivermectin.html | work = Drugs.com |access-date=January 16, 2016 |url-status=live |archive-url= https://web.archive.org/web/20160101113118/http://www.drugs.com/breastfeeding/ivermectin.html |archive-date=January 1, 2016|df=mdy-all}}</ref> It belongs to the [[avermectin]] family of medications.<ref name=AHFS2016 /> It works by causing the parasite's [[cell membrane]] to increase in [[Semipermeable membrane|permeability]], resulting in paralysis and death.<ref name=AHFS2016/>\n\n<!-- Society and culture -->\nIvermectin was discovered in 1975 and came into medical use in 1981.<ref name=Meh2008>{{cite book |last1=Mehlhorn |first1=Heinz | name-list-format = vanc |title=Encyclopedia of parasitology |date=2008 |publisher=Springer |location=Berlin |isbn=978-3-540-48994-8 |page=646 |edition=3rd |url=https://books.google.com/books?id=Jpg1ysgVn-AC&pg=PA646 |url-status=live |archive-url=https://web.archive.org/web/20160131155507/https://books.google.com/books?id=Jpg1ysgVn-AC&pg=PA646 |archive-date=January 31, 2016 |df=mdy-all}}</ref><ref>{{cite book| veditors = Vercruysse J, Rew RS |title=Macrocyclic lactones in antiparasitic therapy|date=2002|publisher=CABI Pub.|location=Oxon, UK|isbn=978-0-85199-840-4|page=Preface|url=https://books.google.com/books?id=QXafQ91O74wC&pg=PR13|url-status=live|archive-url=https://web.archive.org/web/20160131121128/https://books.google.com/books?id=QXafQ91O74wC&pg=PR13|archive-date=January 31, 2016|df=mdy-all}}</ref> It is on the [[WHO Model List of Essential Medicines|World Health Organization's List of Essential Medicines]].<ref name=\"WHO21st\">{{cite book | vauthors = ((World Health Organization)) | title = World Health Organization model list of essential medicines: 21st list 2019 | year = 2019 | hdl = 10665/325771 | author-link = World Health Organization | publisher = World Health Organization | location = Geneva | id = WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO | hdl-access=free }}</ref> The wholesale cost in the [[developing world]] for the tablets is about US$0.12 for a course of treatment.<ref name=MSH2014>{{cite web|title=Ivermectin|url=https://www.msh.org/resources/international-medical-products-price-guide?DMFId=1376&searchYear=2014 |website=International Medical Products Price Guide|access-date=April 6, 2020}}</ref> In the United States, the costs is less than US$50.<ref name=Ric2014>{{cite book |last1=Hamilton |first1=Richard J. | name-list-format = vanc |title=Tarascon pocket pharmacopoeia : 2014 deluxe lab-pocket edition|date=2014|publisher=Jones & Bartlett Learning|location=Sudbury|isbn=978-1-284-05399-9|page=40|edition=15th|url=https://books.google.com/books?id=BwqEAgAAQBAJ&pg=PA40|url-status=live|archive-url=https://web.archive.org/web/20160131114409/https://books.google.com/books?id=BwqEAgAAQBAJ&pg=PA40|archive-date=January 31, 2016|df=mdy-all}}</ref><ref>{{cite web |title=NADAC as of 2019-09-25 {{!}} Data.Medicaid.gov |url=https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-09-25/s3gx-n3zd |website=Centers for Medicare and Medicaid Services |accessdate=26 September 2019 |language=en}}</ref> In other animals it is used to prevent and treat [[heartworm]] among other diseases.<ref name=Sau2015>{{cite book|title=Saunders Handbook of Veterinary Drugs: Small and Large Animal|date=2015|publisher=Elsevier Health Sciences|isbn=978-0-323-24486-2|page=420|edition=4|url=https://books.google.com/books?id=SJvmCgAAQBAJ&pg=PA420|url-status=live|archive-url=https://web.archive.org/web/20160131142826/https://books.google.com/books?id=SJvmCgAAQBAJ&pg=PA420|archive-date=January 31, 2016|df=mdy-all}}</ref>\n\n== Medical uses ==\n===Pinworms===\nIvermectin is as effective as albendazole or alternative antinematode drugs for treatment of [[pinworm infection]] (enterobiasis).<ref>{{cite journal | vauthors = Ottesen EA, Campbell WC | title = Ivermectin in human medicine | journal = The Journal of Antimicrobial Chemotherapy | volume = 34 | issue = 2 | pages = 195\u2013203 | date = August 1994 | pmid = 7814280 | doi =  10.1093/jac/34.2.195}}</ref>\n\n===River blindness===\nIvermectin is used for prevention, treatment, and control of [[onchocerciasis|river blindness]] (onchocerciasis) in populations where the disease is common. However, ivermectin is contraindicated in persons with a high burden of [[loiasis]] (e.g., >20,000 Loa loa microfilariae per mL), due to risk of ivermectin-associated severe inflammatory events.<ref>{{cite journal | vauthors = Keating J, Yukich JO, Mollenkopf S, Tediosi F | title = Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: a systematic review | journal = Acta Tropica | volume = 135 | issue =  | pages = 86\u201395 | date = July 2014 | pmid = 24699086 | doi = 10.1016/j.actatropica.2014.03.017 }}</ref>\n\nA single dose of ivermectin reduces microfilaridermia by 98\u201399% after 1\u20132 months.<ref>{{cite journal | vauthors = Bas\u00e1\u00f1ez MG, Pion SD, Boakes E, Filipe JA, Churcher TS, Boussinesq M |url= https://www.academia.edu/10555590 | title = Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis | journal = The Lancet. Infectious Diseases | volume = 8 | issue = 5 | pages = 310\u201322 | date = May 2008 | pmid = 18471776 | doi = 10.1016/S1473-3099(08)70099-9 }}</ref> Ivermectin does not kill adult worms. A single oral dose of ivermectin, taken once or twice a year for the 10{{ndash}}15-year lifespan of the adult worms, is required to protect the individual from river blindness.<ref name=\"UFAR Treatment\">{{cite web|author=United Front Against Riverblindness |title=Control of Riverblindness |url=http://www.riverblindness.org/index.php?menu=tn3&page=Treatment |archive-url=https://web.archive.org/web/20070827154413/http://www.riverblindness.org/index.php?menu=tn3&page=Treatment |archive-date=August 27, 2007 |url-status=dead }}</ref>\n\nA 2012 [[Cochrane (organisation)|Cochrane review]] found weak evidence suggesting that ivermectin could result in the reduction of chorioretinal lesions and prevent loss of vision in people with river blindness.<ref name=\"Ejere\">{{cite journal | vauthors = Ejere HO, Schwartz E, Wormald R, Evans JR | title = Ivermectin for onchocercal eye disease (river blindness) | journal = The Cochrane Database of Systematic Reviews | volume = 8 | issue = 8 | pages = CD002219 | date = August 2012 | pmid = 22895928 | pmc = 4425412 | doi = 10.1002/14651858.CD002219.pub2 }}</ref> [[Moxidectin]] has been approved by the FDA for use in people with river blindness, has a longer half-life than ivermectin, and may eventually supplant ivermectin, as it is a more potent microfilaricide, but there is a need for additional clinical trials, with long-term follow-up, to assess whether moxidectin is safe and effective for treatment of nematode infection in children and women of childbearing potential.<ref>{{cite journal | vauthors = Maheu-Giroux M, Joseph SA | title = Moxidectin for deworming: from trials to implementation | journal = The Lancet. Infectious Diseases | volume = 18 | issue = 8 | pages = 817\u2013819 | date = August 2018 | pmid = 29858152 | doi = 10.1016/S1473-3099(18)30270-6 }}</ref><ref>{{cite journal | vauthors = Boussinesq M | title = A new powerful drug to combat river blindness | journal = Lancet | volume = 392 | issue = 10154 | pages = 1170\u20131172 | date = October 2018 | pmid = 29361336 | doi = 10.1016/S0140-6736(18)30101-6 }} {{open access}}</ref>\n\n===Loa loa filariasis===\nA single dose of ivermectin gives a rapid and durable decrease in body burden of [[Loa loa|eyeworm]] (''Loa loa''). The risk of ivermectin-associated severe adverse drug events is very low in persons with less than 20,000 microfilariae per mL of blood.<ref>{{cite journal | vauthors = Pion SD, Tchatchueng-Mbougua JB, Chesnais CB, Kamgno J, Gardon J, Chippaux JP, Ranque S, Ernould JC, Garcia A, Boussinesq M | display-authors = 6 | title = Loa loa Microfilaremia: Systematic Review and Meta-analysis | journal = Open Forum Infectious Diseases | volume = 6 | issue = 4 | pages = ofz019 | date = April 2019 | pmid = 30968052 | pmc = 6449757 | doi = 10.1093/ofid/ofz019 }}</ref>\n\n===Threadworm===\nIvermectin is more effective than albendazole and equally as effective as thiabendazole for treatment of [[Pinworm (parasite)|threadworm]] (enterobiasis). Ivermectin has fewer adverse effects than does thiabendazole and is at least as well tolerated as albendazole.<ref>{{cite journal | vauthors = Henriquez-Camacho C, Gotuzzo E, Echevarria J, White AC, Terashima A, Samalvides F, P\u00e9rez-Molina JA, Plana MN | title = Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection | journal = The Cochrane Database of Systematic Reviews | volume =  | issue = 1 | pages = CD007745 | date = January 2016 | pmid = 26778150 | pmc = 4916931 | doi = 10.1002/14651858.CD007745.pub3 }}</ref> An analysis based on an economic model suggests that it is cost effective for people moving to Europe from areas where threadworm is common to be given a single-dose of ivermectin on arrival so as to cure presumptive infection with threadworm.<ref>{{cite journal |vauthors=Agbata EN, Morton RL, Bisoffi Z, Bottieau E, Greenaway C, Biggs BA, Montero N, Tran A, Rowbotham N, Arevalo-Rodriguez I, Myran DT, Noori T, Alonso-Coello P, Pottie K, Requena-M\u00e9ndez A |title=Effectiveness of Screening and Treatment Approaches for Schistosomiasis and Strongyloidiasis in Newly-Arrived Migrants from Endemic Countries in the EU/EEA: A Systematic Review |journal=Int J Environ Res Public Health |volume=16 |issue=1 |pages= 11|date=December 2018 |pmid=30577567 |doi=10.3390/ijerph16010011 |url=|pmc=6339107 }}</ref> Persons who are immunocompromised or who will receive immunosuppressive treatment and who have confirmed or presumptive threadworm infestation are likely to benefit from treatment with ivermectin.<ref>{{cite book | last1=Kotton | first1=Camille | last2=Mileno | first2=Maria | first3 = J. |last3 = Keystone | name-list-format = vanc | title = Travel medicine | chapter = The Immunocompromised Traveler| pages = 269\u2013277 | publisher = Elsevier | location = Edinburgh | year = 2019 | isbn = 978-0-323-54696-6 }}</ref>\n\n===Whipworm===\nCombination therapy with ivermectin plus albendazole is effective for treatment of [[Trichuris trichiura|whipworm]] (''Trichuris trichiura'') and the rate of [[Mazzotti reaction]] is no higher than for albendazole alone.<ref>{{cite journal | vauthors = Palmeirim MS, H\u00fcrlimann E, Knopp S, Speich B, Belizario V, Joseph SA, Vaillant M, Olliaro P, Keiser J | title = Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: A systematic review, meta-analysis and individual patient data analysis | journal = PLoS Neglected Tropical Diseases | volume = 12 | issue = 4 | pages = e0006458 | date = April 2018 | pmid = 29702653 | pmc = 5942849 | doi = 10.1371/journal.pntd.0006458 }}</ref>\n\n===Lymphatic filariasis===\nCombination therapy with ivermectin plus albendazole is effective for treatment of [[Lymphatic filariasis]] due to ''[[Wuchereria bancrofti]]'',<ref>{{cite journal | vauthors = de Kraker ME, Stolk WA, van Oortmarssen GJ, Habbema JD | title = Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti | journal = Tropical Medicine & International Health | volume = 11 | issue = 5 | pages = 718\u201328 | date = May 2006 | pmid = 16640625 | doi = 10.1111/j.1365-3156.2006.01606.x }} {{free access}}</ref> ''[[Brugia malayi]]'', or ''[[Brugia timori]]''.<ref>{{cite journal | vauthors = Taylor MJ, Hoerauf A, Bockarie M | title = Lymphatic filariasis and onchocerciasis | journal = Lancet | volume = 376 | issue = 9747 | pages = 1175\u201385 | date = October 2010 | pmid = 20739055 | doi = 10.1016/S0140-6736(10)60586-7 }}</ref>\n\n=== Arthropod ===\n\nEvidence supports its use against parasitic arthropods and insects:\n* [[Mites]] such as [[scabies]]:<ref name=\"pmid12174005\">{{cite journal | vauthors = Brooks PA, Grace RF | title = Ivermectin is better than benzyl benzoate for childhood scabies in developing countries | journal = Journal of Paediatrics and Child Health | volume = 38 | issue = 4 | pages = 401\u20134 | date = August 2002 | pmid = 12174005 | doi = 10.1046/j.1440-1754.2002.00015.x | url = https://pdfs.semanticscholar.org/a1cd/123fb05e94a926deb6daf430768e230bf88c.pdf }}</ref><ref name=\"pmid11207977\">{{cite journal | vauthors = Victoria J, Trujillo R |url= https://www.academia.edu/28824816 | title = Topical ivermectin: a new successful treatment for scabies | journal = Pediatric Dermatology | volume = 18 | issue = 1 | pages = 63\u20135 | year = 2001 | pmid = 11207977 | doi = 10.1046/j.1525-1470.2001.018001063.x }}</ref><ref name=\"pmid17636630\">{{cite journal | vauthors = Strong M, Johnstone P | title = Interventions for treating scabies | journal = The Cochrane Database of Systematic Reviews | volume =  | issue = 3 | pages = CD000320 | date = July 2007 | pmid = 17636630 | pmc = 6532717 | doi = 10.1002/14651858.CD000320.pub2 | veditors = Strong M }}</ref> It is usually limited to cases that prove to be resistant to topical treatments or that present in an advanced state (such as [[Norwegian scabies]]).<ref name=\"pmid17636630\" /> One review found that the efficacy of permethrin is similar to that of systemic or topical ivermectin.<ref>{{cite journal |vauthors=Rosumeck S, Nast A, Dressler C |title=Ivermectin and permethrin for treating scabies |journal=Cochrane Database Syst Rev |volume=4 |issue= |pages=CD012994 |date=April 2018 |pmid=29608022 |pmc=6494415 |doi=10.1002/14651858.CD012994 |url=}}</ref> A separate review found that although oral ivermectin is usually effective for treatment of scabies, it does have a higher treatment failure rate than topical permethrin.<ref>{{cite journal | vauthors = Dhana A, Yen H, Okhovat JP, Cho E, Keum N, Khumalo NP | title = Ivermectin versus permethrin in the treatment of scabies: A systematic review and meta-analysis of randomized controlled trials | journal = Journal of the American Academy of Dermatology | volume = 78 | issue = 1 | pages = 194\u2013198 | date = January 2018 | pmid = 29241784 | doi = 10.1016/j.jaad.2017.09.006 }}</ref> Another review found that oral ivermectin provided a reasonable balance between efficacy and safety.<ref name=\"Thadanipon2019\">{{cite journal|vauthors=Thadanipon K, Anothaisintawee T, Rattanasiri S, Thakkinstian A, Attia J | title=Efficacy and safety of antiscabietic agents: A systematic review and network meta-analysis of randomized controlled trials. | journal=J Am Acad Dermatol | year= 2019 | volume=  80| issue=  5| pages=  1435\u20131444| pmid=30654070 | doi=10.1016/j.jaad.2019.01.004 | pmc= }} {{open access}} </ref> Since ivermectin is more convenient than permethrin,<ref>{{cite journal | vauthors = Crump A, \u014cmura S | title = Ivermectin, 'wonder drug' from Japan: the human use perspective | journal = Proceedings of the Japan Academy. Series B, Physical and Biological Sciences | volume = 87 | issue = 2 | pages = 13\u201328 | date = 10 February 2011 | pmid = 21321478 | pmc = 3043740 | doi = 10.2183/pjab.87.13 | bibcode = 2011PJAB...87...13C }}</ref> many have turned to veterinary sources of the drug to obtain assurance of a cure at an affordable price.<ref>{{cite journal | vauthors = Laing R, Gillan V, Devaney E | title = Ivermectin - Old Drug, New Tricks? | journal = Trends in Parasitology | volume = 33 | issue = 6 | pages = 463\u2013472 | date = June 2017 | pmid = 28285851 | pmc = 5446326 | doi = 10.1016/j.pt.2017.02.004 }} {{open access}}</ref>\n* [[louse|Lice]]:<ref name=\"Dourmishev AL 2004\">{{cite journal | vauthors = Dourmishev AL, Dourmishev LA, Schwartz RA |url= https://www.academia.edu/33924249 | title = Ivermectin: pharmacology and application in dermatology | journal = International Journal of Dermatology | volume = 44 | issue = 12 | pages = 981\u20138 | date = December 2005 | pmid = 16409259 | doi = 10.1111/j.1365-4632.2004.02253.x }}</ref><ref>{{cite journal | vauthors = Strycharz JP, Yoon KS, Clark JM | title = A new ivermectin formulation topically kills permethrin-resistant human head lice (Anoplura: Pediculidae) | journal = Journal of Medical Entomology | volume = 45 | issue = 1 | pages = 75\u201381 | date = January 2008 | pmid = 18283945 | doi = 10.1603/0022-2585(2008)45[75:ANIFTK]2.0.CO;2 }}</ref> Ivermectin lotion (0.5%) is FDA-approved for patients six months of age and older.<ref>{{cite web | url = https://www.drugs.com/sklice.html | title = Sklice lotion | archive-url =   https://web.archive.org/web/20120512075611/http://www.drugs.com/sklice.html | archive-date = 12 May 2012 | work = drugs.com }}</ref> After a single, 10-minute application of this formulation on dry hair, 78% of subjects were found to be free of lice after two weeks.<ref name=nejm>{{cite journal | vauthors = Pariser DM, Meinking TL, Bell M, Ryan WG | title = Topical 0.5% ivermectin lotion for treatment of head lice | journal = The New England Journal of Medicine | volume = 367 | issue = 18 | pages = 1687\u201393 | date = 1 November 2012 | pmid = 23113480 | doi = 10.1056/NEJMoa1200107 }} {{free access}}</ref> This level of effectiveness is equivalent to other [[pediculicide]] treatments requiring two applications.<ref>{{cite web | first = Melissa | last = Healy | name-list-format = vanc |publisher=Los Angeles Times |date= 1 November 2012 |title=New treatment for lice is highly effective, study reports  | url = https://web.archive.org/web/20200101192821/https://www.latimes.com/health/la-xpm-2012-nov-01-la-heb-lice-treatment-20121101-story.html }}</ref>\n* [[Cimex|Bedbug]]s: There is tentative evidence that ivermectin kills [[bedbug]]s, as part of [[integrated pest management]] for [[bedbug infestation]]s.<ref>{{cite journal |vauthors=Crump A |title=Ivermectin: enigmatic multifaceted 'wonder' drug continues to surprise and exceed expectations |journal=J. Antibiot. |volume=70 |issue=5 |pages=495\u2013505 |date=May 2017 |pmid=28196978 |doi=10.1038/ja.2017.11 }} {{free access}}</ref><ref>{{cite journal |vauthors=\u014cmura S |title=A Splendid Gift from the Earth: The Origins and Impact of the Avermectins (Nobel Lecture) |journal=Angew. Chem. Int. Ed. Engl. |volume=55 |issue=35 |pages=10190\u2013209 |date=August 2016 |pmid=27435664 |doi=10.1002/anie.201602164 |url=https://www.nobelprize.org/prizes/medicine/2015/omura/lecture/ }}</ref><ref>{{cite book |last1=James |first1=William D. |last2=Elston |first2=Dirk |last3=Berger |first3=Timothy |last4=Neuhaus |first4=Isaac | name-list-format = vanc |title=Andrews' Diseases of the Skin: Clinical Dermatology |date=2015 |publisher=Elsevier Health Sciences |isbn=9780323319690 |page=439 |url=https://books.google.com/books?id=Np6cCQAAQBAJ&pg=PA439 |language=en |quote=Ivermectin treatment is emerging as a potential ancillary measure.}}</ref> Such use however may required a prolonged course of treatment which is of unclear safety.<ref>{{cite book |last1=Lebwohl |first1=Mark G. |last2=Heymann |first2=Warren R. |last3=Berth-Jones |first3=John |last4=Coulson |first4=Ian | name-list-format = vanc |title=Treatment of Skin Disease: Comprehensive Therapeutic Strategies |date=2017 |publisher=Elsevier Health Sciences |isbn=9780702069130 |page=89 |url=https://books.google.com/books?id=KuM2DwAAQBAJ&pg=PA89 |language=en}}</ref>\n* [[Malaria]]-bearing [[mosquito]]s, such as [[Anopheles gambiae]]: Mass drug administration of a population with ivermectin for purposes of treating/preventing nematode infestation is effective for eliminating malaria-bearing mosquitos and thereby reducing infection with residual [[Plasmodium falciparum|malaria parasites]].<ref>{{cite journal |vauthors=Tizifa TA, Kabaghe AN, McCann RS, van den Berg H, Van Vugt M, Phiri KS |title=Prevention Efforts for Malaria |journal=Curr Trop Med Rep |volume=5 |issue=1 |pages=41\u201350 |date=2018 |pmid=29629252 |pmc=5879044 |doi=10.1007/s40475-018-0133-y |url=}}</ref>\n\n=== Rosacea ===\nA review found that ivermectin was effective for treatment of [[rosacea]].<ref>{{cite journal |vauthors=Siddiqui K, Stein Gold L, Gill J |title=The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis |journal=SpringerPlus |volume=5 |issue=1 |pages=1151 |date=2016 |pmid=27504249 |pmc=4956638 |doi=10.1186/s40064-016-2819-8 |url=}}</ref> An ivermectin cream has been approved by the [[FDA]], as well as in Europe, for the treatment of inflammatory [[lesion]]s of [[rosacea]]. The treatment is based upon the hypothesis that parasitic mites of the genus ''[[Demodex]]'' play a role in rosacea.<ref>{{cite journal |vauthors=Moran EM, Foley R, Powell FC |title=Demodex and rosacea revisited |journal=Clin. Dermatol. |volume=35 |issue=2 |pages=195\u2013200 |date=2017 |pmid=28274359 |doi=10.1016/j.clindermatol.2016.10.014 |url=}}</ref> In a clinical study, ivermectin reduced lesions by 83% over 4 months, as compared to 74% under a [[metronidazole]] standard therapy.<ref>{{cite web | url = https://www.drugs.com/newdrugs/galderma-receives-fda-approval-soolantra-ivermectin-cream-rosacea-4135.html | title = Galderma Receives FDA Approval of Soolantra (Ivermectin) Cream for Rosacea | archive-url = https://web.archive.org/web/20150122021246/http://www.drugs.com/newdrugs/galderma-receives-fda-approval-soolantra-ivermectin-cream-rosacea-4135.html | archive-date=January 22, 2015 | work = drugs.com }}\"</ref>\n\n== Contraindications ==\nIvermectin is contraindicated in children under the age of five or those who weigh less than {{convert|15|kg|abbr=off}},<ref name=\"Dourmishev AL 2004\"/> women who are breastfeeding, and individuals with liver or kidney disease.<ref>{{cite journal | vauthors = Heukelbach J, Winter B, Wilcke T, Muehlen M, Albrecht S, de Oliveira FA, Kerr-Pontes LR, Liesenfeld O, Feldmeier H | title = Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population | journal = Bulletin of the World Health Organization | volume = 82 | issue = 8 | pages = 563\u201371 | date = August 2004 | pmid = 15375445 | pmc = 2622929 | url = https://scielosp.org/pdf/bwho/2004.v82n8/563-571/en }}</ref>\n\n== Adverse effects ==\n\nThe main concern is neurotoxicity, which in most mammalian species may manifest as [[central nervous system depression]], and consequent [[ataxia]], as might be expected from potentiation of inhibitory GABA-ergic synapses.\n\nDogs with defects in the [[P-glycoprotein]] gene (''MDR1''), often collie-like herding dogs, can be severely poisoned by ivermectin. The mnemonic \"white feet, don't treat\" refers to Scotch collies that are vulnerable to ivermectin.<ref>{{cite journal |vauthors=Dowling P |title=Pharmacogenetics: it's not just about ivermectin in collies |journal=Can. Vet. J. |volume=47 |issue=12 |pages=1165\u20138 |date=December 2006 |pmid=17217086 |pmc=1636591 |doi= |url=}}</ref>\n\nSince drugs that inhibit the enzyme [[CYP3A4]] often also inhibit P-glycoprotein transport, the risk of increased absorption past the blood-brain barrier exists when ivermectin is administered along with other CYP3A4 inhibitors. These drugs include statins, HIV protease inhibitors, many calcium channel blockers, lidocaine, the benzodiazepines, and glucocorticoids such as dexamethasone.<ref>[https://dvmbooks.weebly.com/uploads/2/2/3/6/22365786/2._goodman_and_gilman.pdf#page=148&zoom=auto,-29,535 Goodman and Gilman's The Pharmacological Basis of Therapeutics], 11th edition, pages 122, 1084\u20131087.</ref>\n\nFor dogs, the insecticide [[spinosad]] may have the effect of increasing the potency of ivermectin.<ref>{{cite web|title=COMFORTIS\u00ae and ivermectin interaction Safety Warning Notification|url=https://www.fda.gov/animalveterinary/newsevents/cvmupdates/ucm047942.htm|publisher=U.S. Food and Drug Administration (FDA) Center for Veterinary Medicine (CVM)|archive-url=https://web.archive.org/web/20090829064135/https://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm047942.htm|archive-date=August 29, 2009}}</ref>\n\n== Pharmacology ==\n\n=== Pharmacodynamics ===\n\nIvermectin and other avermectins ([[insecticide]]s most frequently used in home-use [[ant]] baits) are [[cyclic compound|macrocyclic]] [[lactones]] derived from the [[bacterium]] ''[[Streptomyces avermitilis]]''. Ivermectin kills by interfering with [[nervous system]] and [[muscle]] function, in particular by enhancing inhibitory [[neurotransmission]].\n\nThe drug binds to glutamate-gated [[chloride channels]] (GluCls) in the membranes of [[invertebrate]] nerve and muscle cells, causing increased permeability to chloride ions, resulting in cellular hyper-polarization, followed by paralysis and death.<ref name=AHFS2016 /><ref name=\"pmid15313134\">{{cite journal | vauthors = Yates DM, Wolstenholme AJ | title = An ivermectin-sensitive glutamate-gated chloride channel subunit from Dirofilaria immitis | journal = International Journal for Parasitology | volume = 34 | issue = 9 | pages = 1075\u201381 | date = August 2004 | pmid = 15313134 | doi = 10.1016/j.ijpara.2004.04.010 }}</ref> GluCls are invertebrate-specific members of the [[Cys-loop]] family of [[ligand-gated ion channel]]s present in [[neuron]]s and [[myocyte]]s.\n\n=== Pharmacokinetics ===\n\nIvermectin can be given by mouth, topically, or via injection. It does not readily cross the [[blood\u2013brain barrier]] of [[mammal]]s due to the presence of [[P-glycoprotein]],<ref>{{cite journal | vauthors = Borst P, Schinkel AH | title = What have we learnt thus far from mice with disrupted P-glycoprotein genes? | journal = European Journal of Cancer | volume = 32A | issue = 6 | pages = 985\u201390 | date = June 1996 | pmid = 8763339 | doi = 10.1016/0959-8049(96)00063-9 }}</ref> (the ''MDR1'' gene mutation affects function of this protein). Crossing may still become significant if ivermectin is given at high doses (in which case, brain levels peak 2\u20135 hours after administration).\nIn contrast to mammals, ivermectin can cross the blood\u2013brain barrier in tortoises, often with fatal consequences.\n\n=== Ecotoxicity ===\n\nField studies have demonstrated the dung of animals treated with ivermectin supports a significantly reduced diversity of invertebrates, and the dung persists longer.<ref>{{cite journal | vauthors = Iglesias LE, Saumell CA, Fern\u00e1ndez AS, Fus\u00e9 LA, Lifschitz AL, Rodr\u00edguez EM, Steffan PE, Fiel CA |url= https://www.researchgate.net/publication/6964038 | title = Environmental impact of ivermectin excreted by cattle treated in autumn on dung fauna and degradation of faeces on pasture | journal = Parasitology Research | volume = 100 | issue = 1 | pages = 93\u2013102 | date = December 2006 | pmid = 16821034 | doi = 10.1007/s00436-006-0240-x }}</ref>\n\n== History ==\n\nThe discovery of the [[avermectin]] family of compounds, from which ivermectin is chemically derived, was made by [[Satoshi \u014cmura]] of Kitasato University, Tokyo and [[William C. Campbell (scientist)|William C. Campbell]] of the Merck Institute for Therapeutic research. \u014cmura identified avermectin from the bacterium ''[[Streptomyces avermitilis]]''. Campbell purified avermectin from cultures obtained from \u014cmura and led efforts leading to the discovery of ivermectin, a derivative of greater potency and lower toxicity.<ref>{{cite journal | vauthors = Fisher MH, Mrozik H | title = The chemistry and pharmacology of avermectins | journal = Annual Review of Pharmacology and Toxicology | volume = 32 | issue =  | pages = 537\u201353 | year = 1992 | pmid = 1605577 | doi = 10.1146/annurev.pa.32.040192.002541 }} {{free access}}</ref> Ivermectin was introduced in 1981.<ref>{{cite book | vauthors = Campbell WC, Burg RW, Fisher MH, Dybas RA | chapter = Chapter 1: The discovery of ivermectin and other avermectins |title=Pesticide Synthesis Through Rational Approaches|volume=255 | pages = 5\u201320 |date=June 26, 1984 |publisher=American Chemical Society|doi=10.1021/bk-1984-0255.ch001|isbn=978-0-8412-1083-7|series=ACS Symposium Series}} {{free access}}</ref> Half of the 2015 [[Nobel Prize in Physiology or Medicine]] was awarded jointly to Campbell and \u014cmura for discovering avermectin, \"the  derivatives  of which have radically lowered the incidence of [[Onchocerciasis|river blindness]] and [[lymphatic filariasis]], as well as showing efficacy against an expanding number of other  parasitic diseases\".<ref name=\"nobel-2015\">{{cite web|url=https://www.nobelprize.org/nobel_prizes/medicine/laureates/2015/press.pdf|title=The Nobel Prize in Physiology or Medicine 2015|publisher=Nobel Foundation|access-date=October 7, 2015|url-status=live|archive-url=https://web.archive.org/web/20151006112430/http://www.nobelprize.org/nobel_prizes/medicine/laureates/2015/press.pdf|archive-date=October 6, 2015|df=mdy-all}}</ref>\n\n==Society and culture==\n===Cost===\nThe wholesale cost in the [[developing world]] is about US$0.12 for a course of treatment as of 2014.<ref name=MSH2014/> This is down from an initial cost of US$6 proposed by Merck in 1987.<ref name=Crump2011>{{cite journal | vauthors = Crump A, \u014cmura S | title = Ivermectin, 'wonder drug' from Japan: the human use perspective | journal = Proceedings of the Japan Academy. Series B, Physical and Biological Sciences | volume = 87 | issue = 2 | pages = 13\u201328 | date = 2011 | pmid = 21321478 | pmc = 3043740 | doi = 10.2183/pjab.87.13 | bibcode = 2011PJAB...87...13C }}</ref> The company however has donated 100s of millions of courses of treatments since 1988 in more than 30 countries.<ref name=Crump2011/> Between 1995 and 2010 the program using donated ivermectin to prevent river blindness is estimated to have prevented 7 million years of disability well costing US$257 million.<ref>{{cite book |last1=Omaswa |first1=Francis |last2=Crisp |first2=Nigel | name-list-format = vanc |title=African Health Leaders: Making Change and Claiming the Future |date=2014 |publisher=OUP Oxford |isbn=9780191008412 |page=PT158 |url=https://books.google.com/books?id=e0nYBAAAQBAJ&pg=PT158 |language=en}}</ref>\n\nIn the United States a course of treatment with pills costs about US$25\u201350 for a typical adult.<ref name=Ric2014/> As of 2019 ivermectin tablets were the least expensive treatment option for lice in children at about US$10.<ref name=Nelson2019>{{cite book |last1=Kliegman |first1=Robert M. |last2= St Geme |first2=Joseph | name-list-format = vanc |title=Nelson Textbook of Pediatrics E-Book |date=2019 |publisher=Elsevier Health Sciences |isbn=9780323568883 |page=3575 |url=https://books.google.com/books?id=LJuRDwAAQBAJ&pg=PA3867 |language=en}}</ref> The hair lotion, however, is about US$300 for a course of treatment.<ref name=Nelson2019/>\n\n=== Brand names ===\nIvermectin is available as a generic prescription drug in the U.S. in a 3&nbsp;mg tablet formulation.<ref>{{cite web |last1=U.S. FDA |title=Abbreviated New Drug Application (ANDA): 204154 |url=https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204154 |website=Drugs@FDA: FDA Approved Drug Products |publisher=U.S. Food and Drug Administration |access-date=18 August 2018}}</ref> It is also sold under the brand names Heartgard, Sklice<ref>{{cite web|url=http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c5557cd-c4cf-11df-851a-0800200c9a66|title=SKLICE- ivermectin lotion (NDC Code(s): 49281-183-71)|website=DailyMed|date=February 2012|access-date=September 9, 2015|url-status=live|archive-url=https://web.archive.org/web/20160306023406/http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c5557cd-c4cf-11df-851a-0800200c9a66|archive-date=March 6, 2016|df=mdy-all}}</ref> and Stromectol<ref>{{cite web|url=http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=681888c9-af79-4b7d-ae80-c3f4f6f1effd|title=STROMECTOL- ivermectin tablet (NDC Code(s): 0006-0032-20)|website=DailyMed|date=May 2010|access-date=September 9, 2015|url-status=live|archive-url=https://web.archive.org/web/20160306025605/http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=681888c9-af79-4b7d-ae80-c3f4f6f1effd|archive-date=March 6, 2016|df=mdy-all}}</ref> in the United States, Ivomec worldwide by Merial Animal Health, Mectizan in Canada by [[Merck & Co.|Merck]], Iver-DT<ref>{{cite web|title = ALIVE PHARMACEUTICAL (P) LTD.: Iver-DT|url = http://alivepharmaceutical.blogspot.com/2014/05/iver-dt.html|website = ALIVE PHARMACEUTICAL (P) LTD.|date = May 27, 2014|access-date = October 7, 2015|first = Santosh|last = Adhikari | name-list-format = vanc |url-status = live |archive-url = https://web.archive.org/web/20160304223410/http://alivepharmaceutical.blogspot.com/2014/05/iver-dt.html |archive-date = March 4, 2016 |df = mdy-all}}</ref> in Nepal by Alive Pharmaceutical and Ivexterm in Mexico by [[Valeant Pharmaceuticals International]]. In Southeast Asian countries, it is marketed by Delta Pharma Ltd. under the trade name Scabo 6. The formulation for rosacea treatment is sold as Soolantra. While in development, it was assigned the code MK-933 by Merck.<ref>{{cite journal | vauthors = Pampiglione S, Majori G, Petrangeli G, Romi R | title = Avermectins, MK-933 and MK-936, for mosquito control | journal = Transactions of the Royal Society of Tropical Medicine and Hygiene | volume = 79 | issue = 6 | pages = 797\u20139 | year = 1985 | pmid = 3832491 | doi = 10.1016/0035-9203(85)90121-X }}</ref>\n\n== Veterinary use ==\n\nIvermectin is routinely used to control parasitic worms in the gastrointestinal tract of [[ruminant animals]]. These parasites normally enter the animal when it is grazing, pass the bowel and set and mature in the intestines, after which they produce eggs which leave the animal via its droppings and can infest new pastures. Ivermectin is effective in killing some, but not all, of these parasites.{{fact|date=September 2019}}\n\nIn dogs it is used to routinely used prevent [[Dirofilaria immitis|heartworm.]]<ref>{{Citation|last=Papich|first=Mark G.|title=Ivermectin|date=2016-01-01|url=http://www.sciencedirect.com/science/article/pii/B9780323244855003235|work=Saunders Handbook of Veterinary Drugs (Fourth Edition)|pages=420\u2013423|editor-last=Papich|editor-first=Mark G.|publisher=W.B. Saunders|language=en|isbn=978-0-323-24485-5|access-date=2020-04-07}}</ref> Some dog breeds (especially the [[Rough Collie]], the [[Smooth Collie]], the [[Shetland Sheepdog]], and the [[Australian Shepherd]]), though, have a high incidence of a certain mutation within the ''[[MDR1]]'' gene (coding for [[P-glycoprotein]]); affected animals are particularly sensitive to the toxic effects of ivermectin.<ref>{{cite web | url = http://www.ashgi.org/articles/mdr1.htm | title = MDR1 FAQs | archive-url = https://web.archive.org/web/20071213125320/http://www.ashgi.org/articles/mdr1.htm | archive-date=December 13, 2007 | publisher = Australian Shepherd Health & Genetics Institute, Inc. }}</ref><ref>{{cite web | url = http://vcpl.vetmed.wsu.edu/vcpl-home | title = Multidrug Sensitivity in Dogs | archive-url = https://web.archive.org/web/20150623212433/http://vcpl.vetmed.wsu.edu/vcpl-home | archive-date = June 23, 2015 | publisher = Washington State University's College of Veterinary Medicine }}</ref> Clinical evidence suggests kittens are susceptible to ivermectin toxicity.<ref>{{cite journal | vauthors = Frischke H, Hunt L | title = Alberta. Suspected ivermectin toxicity in kittens | journal = The Canadian Veterinary Journal | volume = 32 | issue = 4 | pages = 245 | date = April 1991 | pmid = 17423775 | pmc = 1481314 | doi =  }}</ref> A 0.01% ivermectin topical preparation for treating [[ear mite]]s in cats is available.<ref>{{cite web | url=https://www.bi-vetmedica.com/species/pet/products/acarexx.html |title = Acarexx |date = April 11, 2016 | publisher = Boehringer Ingelheim }}</ref>\n\nIvermectin is sometimes used as an [[acaricide]] in reptiles, both by injection and as a diluted spray. While this works well in some cases, care must be taken, as several species of reptiles are very sensitive to ivermectin. Use in turtles is particularly contraindicated.<ref>{{cite book | last = Klingenberg | first = Roger | name-list-format = vanc | title = Understanding reptile parasites: from the experts at Advanced Vivarium Systems | publisher = Advanced Vivarium Systems | location = Irvine, Calif | year = 2007 | isbn = 978-1882770908 }}</ref>\n\n== Research ==\n\nIvermectin is also being studied as a potential antiviral agent against the [[chikungunya]] and [[yellow fever]].<ref>{{cite journal | vauthors = Varghese FS, Kaukinen P, Gl\u00e4sker S, Bespalov M, Hanski L, Wennerberg K, K\u00fcmmerer BM, Ahola T | title = Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses | journal = Antiviral Research | volume = 126 | issue =  | pages = 117\u201324 | date = February 2016 | pmid = 26752081 | doi = 10.1016/j.antiviral.2015.12.012 }}</ref>\n\nIn 2013, this antiparasitic drug was demonstrated as a novel ligand of [[farnesoid X receptor]] (FXR),<ref name=\"pmid25388537\">{{cite journal | vauthors = Carotti A, Marinozzi M, Custodi C, Cerra B, Pellicciari R, Gioiello A, Macchiarulo A |url= https://www.researchgate.net/publication/268231666 | title = Beyond bile acids: targeting Farnesoid X Receptor (FXR) with natural and synthetic ligands | journal = Current Topics in Medicinal Chemistry | volume = 14 | issue = 19 | pages = 2129\u201342 | year = 2014 | pmid = 25388537 | doi = 10.2174/1568026614666141112094058 }}</ref><ref>{{cite journal | vauthors = Jin L, Feng X, Rong H, Pan Z, Inaba Y, Qiu L, Zheng W, Lin S, Wang R, Wang Z, Wang S, Liu H, Li S, Xie W, Li Y | display-authors = 6 | title = The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism | journal = Nature Communications | volume = 4 | pages = 1937 | date = 2013 | pmid = 23728580 | doi = 10.1038/ncomms2924 | bibcode = 2013NatCo...4.1937J }} {{free access}}</ref> a therapeutic target for [[Nonalcoholic Fatty Liver Disease]].<ref>{{cite journal | vauthors = Kim SG, Kim BK, Kim K, Fang S | title = Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease | journal = Endocrinology and Metabolism | volume = 31 | issue = 4 | pages = 500\u2013504 | date = December 2016 | pmid = 28029021 | pmc = 5195824 | doi = 10.3803/EnM.2016.31.4.500 }}</ref>\n\nIvermectin is also of interest in the prevention of [[malaria]], as it is toxic to both the malaria plasmodium itself, and the mosquitos that carry it.<ref>{{cite journal | vauthors = Chaccour C, Hammann F, Rabinovich NR | title = Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety | journal = Malaria Journal | volume = 16 | issue = 1 | pages = 161 | date = April 2017 | pmid = 28434401 | pmc = 5402169 | doi = 10.1186/s12936-017-1801-4 }}</ref><ref>{{cite journal | vauthors = Siewe Fodjo JN, Kugler M, Hotterbeekx A, Hendy A, Van Geertruyden JP, Colebunders R | title = Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions? | journal = Infectious Diseases of Poverty | volume = 8 | issue = 1 | pages = 77 | date = August 2019 | pmid = 31439040 | pmc = 6706915 | doi = 10.1186/s40249-019-0588-7 }}</ref>\n\n===SARS-CoV-2===\nIvermectin inhibits replication of  [[SARS-CoV-2]] ''in vitro'' (in monkey kidney cell cultre) with an [[IC50|IC<sub>50</sub>]] of 2.2 - 2.8 \u00b5M, making it a possible candidate for [[COVID-19 drug repurposing research]].<ref>{{cite journal |last1=Caly |first1=Leon |last2=Druce |first2=Julian D. |last3=Catton |first3=Mike G. |last4=Jans |first4=David A. |last5=Wagstaff |first5=Kylie M. |title=The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro |journal=Antiviral Research |date=April 2020 |pages=104787 |doi=10.1016/j.antiviral.2020.104787}} {{open access}}</ref> Note that the doses used in cell culture would require 10{{sup|4}} larger doses in humans based on this data, which does not look promising as an effective treatment for Covid19.<ref>TWiV 599 | https://www.microbe.tv/twiv/twiv-599/</ref> Moreover, cell culture experiments also showed promise for treating Dengue virus infection, but later failed in animal models.<ref>TWiV 599 | https://www.microbe.tv/twiv/twiv-599/</ref>\n\nOn 10 April 2020, the FDA issued guidance to not use ivermectin intended for animals as treatment for COVID-19 in humans.<ref>{{cite web | title=Do Not Use Ivermectin for Animals as Treatment for COVID-19 in Humans | website=U.S. [[Food and Drug Administration]] (FDA) | date=10 April 2020 | url=https://www.fda.gov/animal-veterinary/product-safety-information/fda-letter-stakeholders-do-not-use-ivermectin-intended-animals-treatment-covid-19-humans | access-date=10 April 2020}}</ref>\n\n== See also ==\n* [[Carter Center]]\n* [[Neglected Diseases|Neglected diseases]]\n* [[United Front Against Riverblindness]]\n\n== References ==\n{{Reflist}}\n\n== External links ==\n* {{cite web | url = https://druginfo.nlm.nih.gov/drugportal/name/ivermectin | publisher = U.S. National Library of Medicine | work = Drug Information Portal | title = Ivermectin }}\n* [http://www.cartercenter.org/health/river_blindness/index.html The Carter Center River Blindness (Onchocerciasis) Control Program]\n* [https://www.youtube.com/watch?v=t96_xbpXH-M Trinity College Dublin. Prof William Campbell \u2013 The Story of Ivermectin]\n* {{cite web|url=https://reference.medscape.com/drug/stromectol-ivermectin-342657|title=ivermectin (Rx) Stromectol |website=Medscape }}\n* {{cite web | title=Ivermectin Topical | website=MedlinePlus | url=https://medlineplus.gov/druginfo/meds/a613011.html }}\n\n{{Anthelmintics}}\n{{Ectoparasiticides}}\n{{Navboxes\n| title = [[Pharmacodynamics]]\n| titlestyle = background:#ccccff\n| list1 = \n{{GABAA receptor positive modulators}}\n{{Glycine receptor modulators}}\n{{Nicotinic acetylcholine receptor modulators}}\n{{Purine receptor modulators}}\n}}\n{{Authority control}}\n{{portal bar|Pharmacy and pharmacology|Medicine}}\n\n[[Category:Acaricides]]\n[[Category:Antiparasitic agents]]\n[[Category:GABAA receptor positive allosteric modulators]]\n[[Category:Glycine receptor agonists]]\n[[Category:Insecticides]]\n[[Category:Japanese inventions]]\n[[Category:Macrolides]]\n[[Category:Merck & Co. brands]]\n[[Category:Nicotinic agonists]]\n[[Category:Peripherally selective drugs]]\n[[Category:Veterinary drugs]]\n[[Category:World Health Organization essential medicines]]\n[[Category:Chloride channel openers]]\n[[Category:RTT]]\n", "name_user": "Amirhussain30001", "label": "unsafe", "comment": "(uses information about ivermectin)", "url_page": "//en.wikipedia.org/wiki/Ivermectin"}
{"title_page": "Patrick Maher (writer)", "text_new": "{{Use mdy dates|date=April 2012}}\n{{Infobox writer <!-- for more information see [[:Template:Infobox writer/doc]] -->\n| name = Patrick Maher\n| image = Portrait of Patrick Maher.jpg|alt=Portrait of American author Patrick Maher by Khun Nan, 2010\n| birth_date = {{birth date and age|1965|5|11}}\n| birth_place = [[East Grand Rapids, Michigan|East Grand Rapids]], [[Michigan]], United States\n| occupation = Author\n| nationality = American\n| genre = Fiction\n| notableworks = Candid Confessions<br/>Pleng's Song}}\n\n'''Patrick Maher''' (born 1965 in [[Grand Rapids, Michigan]]), is an American writer. He has written two books, ''[[Candid Confessions]]'' and ''Pleng's Song''. A third, ''Memories of Gaslight'', remained unpublished.<ref name=\"cybersansar\">{{cite web|last=Glan|first=Latshering|title=Interview with American Author Patrick Maher|url=http://www.cybernepal.com.np/article.php?aid=4219|accessdate=1 March 2013}}</ref>\n\n==Novels==\nMaher's first novel, ''Candid Confessions'', reached No. 1 on Amazon Japan's best seller list in 2001.<ref name=candidmalepig>{{cite web |last=Pesapane |first=Mark |title=Candid Confessions Review |url=//www.malepig.com/candid.php |publisher=Malepig Books |accessdate=13 November 2012 |url-status=dead |archiveurl=https://web.archive.org/web/20020802214235/http://www.malepig.com/candid.php |archivedate=August 2, 2002 |df=mdy-all }}</ref>{{failed verification|date=July 2016}} In May 2008 Maher announced another book, ''Memories of Gaslight'', but it remained unpublished.<ref name=mlive>{{cite web|last=McGrath|first=Shelia|title=EGR graduate brings his recollections to new novel|url=http://www.mlive.com/cadenceadvance/index.ssf/2008/05/egr_graduate_brings_his_recoll.html|accessdate=13 November 2012|url-status=dead|archiveurl=https://web.archive.org/web/20120320045416/http://www.mlive.com/cadenceadvance/index.ssf/2008/05/egr_graduate_brings_his_recoll.html|archivedate=March 20, 2012|df=mdy-all}}</ref>\n\nMaher wrote ''Pleng's Song'', a story about a young girl's adventure in the Bangkok floods. The story was inspired by Maher's personal experience of almost drowning in the [[2011 Thailand floods|2011 Thailand Floods]].<ref name=bicol>{{cite web|last=Bicolmail Contributor|title=Gifted American author emerges in Asia|url=http://www.bicolmail.com/2012/?p=2722|publisher=Bicolmail|accessdate=15 November 2012}}</ref><ref name=toi>{{cite web|last=Chopra|first=Rakshit|title=Book Review: Pleng's Song by Patrick Maher|url=http://articles.timesofindia.indiatimes.com/2012-11-08/books/34797370_1_thailand-floods-pleng-s-song-severe-floods|publisher=Times of India|accessdate=14 November 2012}}</ref> The book received mostly positive reviews from ''[[The Nation (Thailand)]]'', ''[[The Times of India]]'', ''[[Rep\u00fablica (Nepalese newspaper)|Rep\u00fablica]]'', ''[[The Kathmandu Post]]'', ''[[Tripoli Post]]'' and ''[[The Himalayan Times]]''.<ref name=jakarta>{{cite web|last=Figge|first=Katrin|title=A Coming-of-Age Story Set Amid the Floods of Thailand|url=http://www.thejakartaglobe.com/lifeandtimes/a-coming-of-age-story-set-amid-the-floods-of-thailand/542751|accessdate=15 November 2012|url-status=dead|archiveurl=https://web.archive.org/web/20120909193352/http://www.thejakartaglobe.com/lifeandtimes/a-coming-of-age-story-set-amid-the-floods-of-thailand/542751|archivedate=September 9, 2012|df=mdy-all}}</ref><ref name=seattle/><ref name=TheRepublica>{{cite web|last=Shrestha|first=Sarah|title=Pleng's Song|url=http://myrepublica.com/portal/index.php?action=news_details&news_id=48455|publisher=TheRepublica|accessdate=1 January 2013|url-status=dead|archiveurl=https://web.archive.org/web/20130928002325/http://myrepublica.com/portal/index.php?action=news_details&news_id=48455|archivedate=September 28, 2013|df=mdy-all}}</ref><ref name=ekantipur>{{cite web|last=Gautam|first=Manish|title=A little voice in the water|url=http://www.ekantipur.com/the-kathmandu-post/2012/08/31/related_articles/a-little-voice-in-the-water/239080.html|accessdate=1 September 2012}}</ref><ref>{{cite web|title=INTERVIEW: Patrick Maher, Author of Pleng\u2019s Song: It is the Human Spirit, Resilience What Matters|url=http://www.tripolipost.com/articledetail.asp?c=15&i=10635|publisher=The Tripoli Post|accessdate=23 September 2013|url-status=dead|archiveurl=https://web.archive.org/web/20130919234617/http://www.tripolipost.com/articledetail.asp?c=15&i=10635|archivedate=September 19, 2013|df=mdy-all}}</ref><ref>{{cite web|title=Book review: Pleng's adventure will hook readers|url=http://www.thehimalayantimes.com/fullNews.php?headline=Book+review%3A+Pleng%27s+adventure+will+hook+readers&NewsID=371876|publisher=The Himalayan Times|accessdate=23 September 2013}}</ref><ref name=\"nationmultimedia\">{{cite web|last=Eckdart|first=James|title=Pleng's excellent flood adventure|url=http://www.nationmultimedia.com/life/Plengs-excellent-flood-adventure-30184760.html|publisher=The Nation|accessdate=13 November 2012}}</ref> \nIn an interview with the ''[[Seattle Post-Intelligencer]]'' and [[Zee News]], Maher said that the book was \"never intended to be a flooding adventure\".<ref name=seattle>{{cite web|last=Stevenson|first=Luanne|title=Interview with Patrick Maher, Author of Pleng's Song|url=http://www.seattlepi.com/lifestyle/blogcritics/article/Interview-with-Patrick-Maher-Author-of-Pleng-s-Song-3694767.php|publisher=Seattle Post Intelligencer|accessdate=13 November 2012}}</ref><ref>{{cite web|title='Pleng\u2019s Song' makes children question their lives: Patrick Maher|url=http://zeenews.india.com/exclusive/plengs-song-makes-children-question-their-lives-patrick-maher_6503.html|publisher=Zee News|accessdate=23 September 2013}}</ref>\n\n==Personal life==\nMaher grew up in [[East Grand Rapids, Michigan]]. He was the son of a pediatric allergist and an emotionally troubled mother.<ref name=cybersansar/> After completing schooling at [[The Hill School]] and [[East Grand Rapids High School]], he studied at [[Skidmore College]] and [[Albion College]].<ref name=cybersansar/> In 1995, Maher immigrated to [[Busan]], South Korea, then to [[Hiroshima]], and later to [[Kokura]], where he wrote ''Candid Confessions''. Five years later, he moved to Thailand, where he married an insurance agent in 2001.<ref name=jakarta/> By 2002 he had settled in the [[Khlong Sam Wa district]] of Bangkok, where {{as of|2008|lc=y}} he works as a schoolteacher.<ref name=mlive/>\n\n== References ==\n{{Reflist|2}}\n\n{{authority control}}\n\n{{DEFAULTSORT:Maher, Patrick}}\n[[Category:1965 births]]\n[[Category:Living people]]\n[[Category:21st-century American novelists]]\n[[Category:American male novelists]]\n[[Category:Writers from Grand Rapids, Michigan]]\n[[Category:The Hill School alumni]]\n[[Category:People from East Grand Rapids, Michigan]]\n[[Category:21st-century American male writers]]\n[[Category:Novelists from Michigan]]\n", "text_old": "{{Use mdy dates|date=April 2012}}\n{{Infobox writer <!-- for more information see [[:Template:Infobox writer/doc]] -->\n| name = Patrick Maher\n| image = Portrait of Patrick Maher.jpg|alt=Portrait of American author Patrick Maher by Khun Nan, 2010\n| birth_date = {{birth date and age|1965|5|11}}\n| birth_place = [[East Grand Rapids, Michigan|East Grand Rapids]], [[Michigan]], United States\n| occupation = Author\n| nationality = American\n| genre = Fiction\n| notableworks = Candid Confessions<br/>Pleng's Song}}\n\n'''Patrick Maher''' (born 1965 in [[Grand Rapids, Michigan]]), is an American writer. He has written two books, ''[[Candid Confessions]]'' and ''Pleng's Song''. A third, ''Memories of Gaslight'', remained unpublished.<ref name=\"cybersansar\">{{cite web|last=Glan|first=Latshering|title=Interview with American Author Patrick Maher|url=http://www.cybernepal.com.np/article.php?aid=4219|accessdate=1 March 2013}}</ref>\n\n==Novels==\nMaher's first novel, ''Candid Confessions'', reached No. 1 on Amazon Japan's best seller list in 2001.<ref name=candidmalepig>{{cite web |last=Pesapane |first=Mark |title=Candid Confessions Review |url=//www.malepig.com/candid.php |publisher=Malepig Books |accessdate=13 November 2012 |url-status=dead |archiveurl=https://web.archive.org/web/20020802214235/http://www.malepig.com/candid.php |archivedate=August 2, 2002 |df=mdy-all }}</ref>{{failed verification|date=July 2016}} In May 2008 Maher announced another book, ''Memories of Gaslight'', but it remained unpublished.<ref name=mlive>{{cite web|last=McGrath|first=Shelia|title=EGR graduate brings his recollections to new novel|url=http://www.mlive.com/cadenceadvance/index.ssf/2008/05/egr_graduate_brings_his_recoll.html|accessdate=13 November 2012|url-status=dead|archiveurl=https://web.archive.org/web/20120320045416/http://www.mlive.com/cadenceadvance/index.ssf/2008/05/egr_graduate_brings_his_recoll.html|archivedate=March 20, 2012|df=mdy-all}}</ref>\n\nMaher wrote ''Pleng's Song'', a story about a young girl's adventure in the Bangkok floods. The story was inspired by Maher's personal experience of almost drowning in the [[2011 Thailand floods|2011 Thailand Floods]].<ref name=bicol>{{cite web|last=Bicolmail Contributor|title=Gifted American author emerges in Asia|url=http://www.bicolmail.com/2012/?p=2722|publisher=Bicolmail|accessdate=15 November 2012}}</ref><ref name=toi>{{cite web|last=Chopra|first=Rakshit|title=Book Review: Pleng's Song by Patrick Maher|url=http://articles.timesofindia.indiatimes.com/2012-11-08/books/34797370_1_thailand-floods-pleng-s-song-severe-floods|publisher=Times of India|accessdate=14 November 2012}}</ref> The book received mostly positive reviews from ''[[The Nation (Thailand)]]'', ''[[The Times of India]]'', ''[[Rep\u00fablica (Nepalese newspaper)|Rep\u00fablica]]'', ''[[The Kathmandu Post]]'', ''[[Tripoli Post]]'' and ''[[The Himalayan Times]]''.<ref name=jakarta>{{cite web|last=Figge|first=Katrin|title=A Coming-of-Age Story Set Amid the Floods of Thailand|url=http://www.thejakartaglobe.com/lifeandtimes/a-coming-of-age-story-set-amid-the-floods-of-thailand/542751|accessdate=15 November 2012|url-status=dead|archiveurl=https://web.archive.org/web/20120909193352/http://www.thejakartaglobe.com/lifeandtimes/a-coming-of-age-story-set-amid-the-floods-of-thailand/542751|archivedate=September 9, 2012|df=mdy-all}}</ref><ref name=seattle/><ref name=TheRepublica>{{cite web|last=Shrestha|first=Sarah|title=Pleng's Song|url=http://myrepublica.com/portal/index.php?action=news_details&news_id=48455|publisher=TheRepublica|accessdate=1 January 2013|url-status=dead|archiveurl=https://web.archive.org/web/20130928002325/http://myrepublica.com/portal/index.php?action=news_details&news_id=48455|archivedate=September 28, 2013|df=mdy-all}}</ref><ref name=ekantipur>{{cite web|last=Gautam|first=Manish|title=A little voice in the water|url=http://www.ekantipur.com/the-kathmandu-post/2012/08/31/related_articles/a-little-voice-in-the-water/239080.html|accessdate=1 September 2012}}</ref><ref>{{cite web|title=INTERVIEW: Patrick Maher, Author of Pleng\u2019s Song: It is the Human Spirit, Resilience What Matters|url=http://www.tripolipost.com/articledetail.asp?c=15&i=10635|publisher=The Tripoli Post|accessdate=23 September 2013|url-status=dead|archiveurl=https://web.archive.org/web/20130919234617/http://www.tripolipost.com/articledetail.asp?c=15&i=10635|archivedate=September 19, 2013|df=mdy-all}}</ref><ref>{{cite web|title=Book review: Pleng's adventure will hook readers|url=http://www.thehimalayantimes.com/fullNews.php?headline=Book+review%3A+Pleng%27s+adventure+will+hook+readers&NewsID=371876|publisher=The Himalayan Times|accessdate=23 September 2013}}</ref><ref name=\"nationmultimedia\">{{cite web|last=Eckdart|first=James|title=Pleng's excellent flood adventure|url=http://www.nationmultimedia.com/life/Plengs-excellent-flood-adventure-30184760.html|publisher=The Nation|accessdate=13 November 2012}}</ref> \nIn an interview with the ''[[Seattle Post-Intelligencer]]'' and [[Zee News]], Maher said that the book was \"never intended to be a flooding adventure\".<ref name=seattle>{{cite web|last=Stevenson|first=Luanne|title=Interview with Patrick Maher, Author of Pleng's Song|url=http://www.seattlepi.com/lifestyle/blogcritics/article/Interview-with-Patrick-Maher-Author-of-Pleng-s-Song-3694767.php|publisher=Seattle Post Intelligencer|accessdate=13 November 2012}}</ref><ref>{{cite web|title='Pleng\u2019s Song' makes children question their lives: Patrick Maher|url=http://zeenews.india.com/exclusive/plengs-song-makes-children-question-their-lives-patrick-maher_6503.html|publisher=Zee News|accessdate=23 September 2013}}</ref>\n\n==Personal life==\nMaher grew up in [[East Grand Rapids, Michigan]]. He was the son of a pediatric allergist and an emotionally troubled mother.<ref name=cybersansar/> After completing schooling at [[The Hill School]] and [[East Grand Rapids High School]], he studied at [[Skidmore College]] and [[Albion College]].<ref name=cybersansar/> In 1995, Maher immigrated to [[Busan]], South Korea, then to [[Hiroshima]], and later to [[Kokura]], where he wrote ''Candid Confessions''. Five years later, he moved to Thailand, where he married an insurance agent in 2001.<ref name=jakarta/> By 2002 he had settled in the [[Khlong Sam Wa district]] of Bangkok, where {{as of|2008|lc=y}} he works as a schoolteacher.<ref name=mlive/>\n\n== References ==\n{{Reflist|2}}\n\n{{DEFAULTSORT:Maher, Patrick}}\n[[Category:1965 births]]\n[[Category:Living people]]\n[[Category:21st-century American novelists]]\n[[Category:American male novelists]]\n[[Category:Writers from Grand Rapids, Michigan]]\n[[Category:The Hill School alumni]]\n[[Category:People from East Grand Rapids, Michigan]]\n[[Category:21st-century American male writers]]\n[[Category:Novelists from Michigan]]\n", "name_user": "Ser Amantio di Nicolao", "label": "safe", "comment": "\u2192\u200eReferences:add authority control", "url_page": "//en.wikipedia.org/wiki/Patrick_Maher_(writer)"}
